id	Pubmed_id	PubmedPublishYear	PubmedPubishMonth	PubmedPublishDay	PubmedEPublishDate	PubmedPublishModel	PubmedType	PubmedJournalTitle	PubmedJournalAbbrev	PubmedJournalISSN	PubmedArticleTitle	PubmedAbstract	PubmedVolume	PubmedIssue	PubmedPages	PubmedDOI	PubmedAuthorsLastName	PubmedAuthorsForeName	PubmedAuthorsAffiliation	PubmedLanguage	PubmedCitations	PubmedRecordStatus	PubmedPubStatus	PubmedComment
1	31744922	2019	11	19		Electronic	Journal Article;Research Support, N.I.H., Extramural	mBio	mBio	2150-7511	The Cyclic AMP Receptor Protein Regulates Quorum Sensing and Global Gene Expression in Yersinia pestis during Planktonic Growth and Growth in Biofilms.	Cyclic AMP (cAMP) receptor protein (Crp) is an important transcriptional regulator of	10	6		10.1128/mBio.02613-19	Ritzert;Minasov;Embry;Schipma;Satchell	Jeremy T;George;Ryan;Matthew J;Karla J F	Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.;Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.;Center for Structural Genomics of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.;Center for Genetic Medicine, Northwestern University, Chicago, Illinois, USA.;Center for Genetic Medicine, Northwestern University, Chicago, Illinois, USA.;Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA k-satchell@northwestern.edu.;Center for Structural Genomics of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.	eng	Bioinformatics. 2015 Jan 15;31(2):166-9;Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):439-50;Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42;J Bacteriol. 2018 Apr 9;200(9):;PLoS One. 2016 May 16;11(5):e0155010;Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):265-70;J Bacteriol. 2012 Nov;194(21):5897-908;J Bacteriol. 2007 Dec;189(24):8890-900;PLoS Genet. 2015 Mar 27;11(3):e1005087;J Bacteriol. 2004 Oct;186(19):6374-82;Methods Enzymol. 2003;374:229-44;Front Cell Infect Microbiol. 2016 Mar 02;6:25;J Mol Biol. 1984 Dec 25;180(4):881-909;Curr Issues Mol Biol. 2006 Jan;8(1):1-10;Mol Microbiol. 2008 Jul;69(1):137-51;Methods Mol Biol. 2009;498:105-15;J Bacteriol. 1990 Nov;172(11):6557-67;Front Microbiol. 2016 Mar 08;7:295;J Bacteriol. 2012 Apr;194(8):2036-40;Infect Immun. 2013 Nov;81(11):4053-62;Curr Opin Microbiol. 2014 Apr;18:1-7;Int J Med Microbiol. 2004 Apr;293(7-8):479-82;Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17786-91;Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21;Methods Mol Biol. 2014;1140:137-43;Microbes Infect. 2011 Sep;13(10):808-17;Microbiology. 2015 Jun;161(6):1198-1210;BMC Microbiol. 2009 Aug 25;9:178;Open Biol. 2016 Mar;6(3):null;Genome Biol. 2014;15(12):550;J Bacteriol. 2013 Nov;195(22):5051-63;J Biol Chem. 2015 Sep 4;290(36):22225-35;Nat Rev Microbiol. 2008 Aug;6(8):613-24;Front Cell Infect Microbiol. 2014 Oct 20;4:146;Mol Microbiol. 2015 Sep;97(6):1114-27;Science. 2007 Jan 26;315(5811):509-13;J Bacteriol. 2013 May;195(9):1920-30;MBio. 2012 Aug 14;3(4):e00217-12;Nat Genet. 2000 May;25(1):25-9;Mol Microbiol. 2004 Oct;54(1):75-88;Cell Host Microbe. 2014 Apr 9;15(4):424-34;MBio. 2014 Feb 11;5(1):e01038-13;MBio. 2015 Feb 17;6(1):e02302-14;EMBO J. 1998 Jun 15;17(12):3439-47;Microbiol Mol Biol Rev. 2014 Jun;78(2):231-56;Metallomics. 2017 Jun 21;9(6):757-772;Infect Immun. 2008 Nov;76(11):5028-37;Mob DNA. 2014 Nov 30;5(1):27;Mol Microbiol. 2012 Nov;86(3):661-74;Trends Microbiol. 2016 Mar;24(3):190-197;Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):E709-17;Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66;Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32;Bioinformatics. 2013 Jan 1;29(1):15-21;Nat Methods. 2005 Jun;2(6):443-8;Roum Arch Microbiol Immunol. 2013 Jan-Mar;72(1):63-86;PLoS One. 2015 Aug 25;10(8):e0135481;PLoS One. 2012;7(12):e52392;PLoS Pathog. 2010 Feb 26;6(2):e1000783;Clin Microbiol Rev. 1997 Jan;10(1):35-66;Infect Immun. 2010 May;78(5):2045-52;J Bacteriol. 2018 May 9;200(11):;Mol Microbiol. 2011 Jan;79(2):533-51;J Bacteriol. 2013 Mar;195(5):1022-30;J Struct Funct Genomics. 2013 Dec;14(4):135-44;J Med Microbiol. 2017 Jan;66(1):1-7;Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426;Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338;J Infect Dis. 2014 Nov 1;210(9):1367-75;J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674;J Bacteriol. 2006 Jun;188(12):4453-63;PLoS One. 2013 Apr 19;8(4):e62337;J Bacteriol. 2014 May;196(9):1659-70;Curr Microbiol. 2016 Jul;73(1):54-64;J Bacteriol. 2012 Apr;194(8):2020-6;Adv Exp Med Biol. 2007;603:178-91	In-Process	epublish
2	31580793	2019	11			Print	Journal Article;Research Support, Non-U.S. Gov't	Microbial genomics	Microb Genom	2057-5858	Genome-wide assessment of antimicrobial tolerance in	i	5	11		10.1099/mgen.0.000304	Willcocks;Huse;Stabler;Oyston;Scott;Atkins;Wren	Samuel;Kristin K;Richard;Petra C F;Andrew;Helen S;Brendan W	The London School of Hygiene and Tropical Medicine, Keppel St., London WC1E 7HT, UK.;The London School of Hygiene and Tropical Medicine, Keppel St., London WC1E 7HT, UK.;The London School of Hygiene and Tropical Medicine, Keppel St., London WC1E 7HT, UK.;Microbiology, CBR Division, DSTL Porton Down, Salisbury SP4 0JQ, UK.;Microbiology, CBR Division, DSTL Porton Down, Salisbury SP4 0JQ, UK.;University of Exeter, Exeter, Devon EX4 4SB, UK.;Microbiology, CBR Division, DSTL Porton Down, Salisbury SP4 0JQ, UK.;The London School of Hygiene and Tropical Medicine, Keppel St., London WC1E 7HT, UK.	eng	Nucleic Acids Res. 2014 Dec 1;42(21):13228-41;J Clin Microbiol. 2001 Oct;39(10):3649-55;Antimicrob Agents Chemother. 2014;58(4):1835-46;Infect Immun. 2010 Jan;78(1):364-71;Antimicrob Agents Chemother. 1987 Jul;31(7):1106-10;J Mol Biol. 1996 May 17;258(4):627-37;Eur J Clin Microbiol Infect Dis. 1995 Sep;14(9):804-10;PLoS Comput Biol. 2015 Oct 08;11(10):e1004401;Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31;Mol Cell. 2009 Dec 11;36(5):845-60;J Biol Chem. 2004 Jan 2;279(1):223-30;PLoS Genet. 2016 Feb 12;12(2):e1005799;Bioorg Chem. 2017 Feb;70:1-11;J Bioinform Comput Biol. 2016 Jun;14(3):1642004;Open Forum Infect Dis. 2015 Dec 17;3(1):ofv202;Front Microbiol. 2016 Mar 31;7:444;Biochem Biophys Res Commun. 2002 Mar 29;292(2):396-401;PLoS One. 2007 Mar 21;2(3):e309;J Biol Chem. 2004 Oct 29;279(44):45546-55;Infect Immun. 2013 Feb;81(2):542-51;Int J Med Microbiol. 2017 Oct;307(7):371-381;Annu Rev Biochem. 1997;66:233-67;J Med Microbiol. 2017 May;66(5):551-559;J Bacteriol. 2012 Aug;194(15):4089-96;Antimicrob Agents Chemother. 2017 Nov 22;61(12):;J Bacteriol. 2011 Apr;193(7):1771-6;PLoS Negl Trop Dis. 2011 Feb 08;5(2):e959;Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5;Appl Microbiol Biotechnol. 2011 Nov;92(3):479-97;Microbiology. 2013 Dec;159(Pt 12):2513-2523;J Bacteriol. 1997 Aug;179(16):5188-94;Biochimie. 1991 Apr;73(4):519-21;Virulence. 2016 Oct 2;7(7):840-5;Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):197-200;BMC Microbiol. 2018 May 31;18(1):46;Antimicrob Agents Chemother. 2006 Mar;50(3):949-54;J Infect Dis. 1992 Oct;166(4):812-7;Genes Dev. 2006 Aug 1;20(15):2121-34;Nephrol Dial Transplant. 2002 Dec;17(12):2252-4;Infect Immun. 2007 Aug;75(8):3913-24;Antimicrob Agents Chemother. 1992 Apr;36(4):819-25;Ann Transl Med. 2015 Dec;3(22):358;Biophys Rev. 2018 Apr;10(2):347-362;Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):1967-1969;Pediatr Infect Dis J. 1988 Oct;7(10):686-9;Infect Immun. 2017 Jul 19;85(8):;J Antimicrob Chemother. 2010 Mar;65(3):520-4;MBio. 2011 Jan 18;2(1):e00315-10;Nat Rev Microbiol. 2013 Jul;11(7):443-54;J Biol Chem. 2005 Apr 8;280(14):14154-67;J Bacteriol. 2009 Feb;191(4):1152-61;Sci Rep. 2017 Feb 15;7:42483;Elife. 2016 Dec 23;5:;BMC Microbiol. 2009 Apr 13;9:69;Microbiol Immunol. 2008 Dec;52(12):565-74;PLoS Genet. 2009 Dec;5(12):e1000760;J Infect Dis. 1995 Feb;171(2):483-6	In-Process	ppublish
3	31534221	2019	10			Print-Electronic	Journal Article;Research Support, N.I.H., Extramural	Nature	Nature	1476-4687	FPR1 is the plague receptor on host immune cells.	The causative agent of plague, Yersinia pestis, uses a type III secretion system to selectively destroy immune cells in humans, thus enabling Y. pestis to reproduce in the bloodstream and be transmitted to new hosts through fleabites. The host factors that are responsible for the selective destruction of immune cells by plague bacteria are unknown. Here we show that LcrV, the needle cap protein of the Y. pestis type III secretion system, binds to the N-formylpeptide receptor (FPR1) on human immune cells to promote the translocation of bacterial effectors. Plague infection in mice is characterized by high mortality; however, Fpr1-deficient mice have increased survival and antibody responses that are protective against plague. We identified FPR1	574	7776	57-62	10.1038/s41586-019-1570-z	Osei-Owusu;Charlton;Kim;Missiakas;Schneewind	Patrick;Thomas M;Hwan Keun;Dominique;Olaf	Howard Taylor Ricketts Laboratory, Argonne National Laboratory, Lemont, IL, USA.;Department of Microbiology, University of Chicago, Chicago, IL, USA.;Howard Taylor Ricketts Laboratory, Argonne National Laboratory, Lemont, IL, USA.;Department of Microbiology, University of Chicago, Chicago, IL, USA.;Howard Taylor Ricketts Laboratory, Argonne National Laboratory, Lemont, IL, USA.;Department of Microbiology, University of Chicago, Chicago, IL, USA.;Howard Taylor Ricketts Laboratory, Argonne National Laboratory, Lemont, IL, USA. dmissiak@bsd.uchicago.edu.;Department of Microbiology, University of Chicago, Chicago, IL, USA. dmissiak@bsd.uchicago.edu.;Howard Taylor Ricketts Laboratory, Argonne National Laboratory, Lemont, IL, USA.;Department of Microbiology, University of Chicago, Chicago, IL, USA.	eng		MEDLINE	ppublish
4	31311844	2019	Jul	16		Electronic	Journal Article	mSystems	mSystems	2379-5077	Hfq Globally Binds and Destabilizes sRNAs and mRNAs in Yersinia pestis.	Hfq is a ubiquitous Sm-like RNA-binding protein in bacteria involved in physiological fitness and pathogenesis, while its	4	4		10.1128/mSystems.00245-19	Han;Chen;Yan;Gao;Liu;Xue;Zhang;Yang	Yanping;Dong;Yanfeng;Xiaofang;Zizhong;Yaqiang;Yi;Ruifu	State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;Center for Genome Analysis, ABLife Inc., Wuhan, Hubei, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;Anhui Medical University, Hefei, Anhui, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;Laboratory for Genome Regulation and Human Health, ABLife Inc., Wuhan, Hubei, China.;Center for Genome Analysis, ABLife Inc., Wuhan, Hubei, China yizhang@ablife.cc ruifuyang@gmail.com.;Laboratory for Genome Regulation and Human Health, ABLife Inc., Wuhan, Hubei, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China yizhang@ablife.cc ruifuyang@gmail.com.	eng	Nature. 2000 Mar 30;404(6777):515-8;Curr Opin Cell Biol. 2000 Jun;12(3):346-50;Mol Microbiol. 2000 Aug;37(4):856-68;Genes Dev. 2001 Jul 1;15(13):1637-51;Curr Biol. 2001 Jun 26;11(12):941-50;Mol Cell. 2002 Jan;9(1):23-30;EMBO J. 2002 Jul 1;21(13):3546-56;Genes Dev. 2003 Oct 1;17(19):2374-83;RNA. 2003 Nov;9(11):1308-14;Mol Microbiol. 2003 Nov;50(4):1111-24;DNA Res. 2004 Jun 30;11(3):179-97;Mol Microbiol. 2004 Nov;54(4):905-20;Trends Genet. 2005 Jul;21(7):399-404;Genes Dev. 2005 Sep 15;19(18):2176-86;BMC Microbiol. 2006 Jun 12;6:52;Curr Opin Microbiol. 2007 Apr;10(2):134-9;Genes Dev. 2007 Nov 1;21(21):2804-17;RNA. 2008 Sep;14(9):1907-17;PLoS Genet. 2008 Aug 22;4(8):e1000163;Mol Cell. 2008 Dec 26;32(6):827-37;Cell. 2009 Feb 20;136(4):615-28;RNA Biol. 2009 Jul-Aug;6(3):266-75;Genome Res. 2009 Sep;19(9):1639-45;PLoS One. 2009 Jul 10;4(7):e6213;Nat Struct Mol Biol. 2009 Aug;16(8):840-6;Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19292-7;Curr Opin Microbiol. 2010 Feb;13(1):24-33;Infect Immun. 2010 May;78(5):2034-44;Proc Natl Acad Sci U S A. 2010 May 25;107(21):9602-7;Nucleic Acids Res. 2010 Aug;38(14):e147;Mol Cell. 2010 May 28;38(4):576-89;Mol Genet Genomics. 2010 Oct;284(4):307-18;Genes Dev. 2010 Dec 1;24(23):2621-6;Genes Dev. 2011 Feb 15;25(4):294-8;Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13065-70;Nat Rev Microbiol. 2011 Aug 15;9(8):578-89;Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13059-64;Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):E709-17;Nat Methods. 2012 Mar 04;9(4):357-9;Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9396-401;EMBO J. 2012 Oct 17;31(20):4005-19;Nucleic Acids Res. 2012 Nov;40(21):11023-35;Mol Cell. 2012 Sep 28;47(6):825-6;Nat Rev Microbiol. 2013 Jan;11(1):45-57;RNA Biol. 2013 Mar;10(3):397-405;J Biol Chem. 2013 Mar 22;288(12):7996-8003;RNA Biol. 2013 Apr;10(4):619-26;Genes Dev. 2013 Mar 1;27(5):552-64;RNA Biol. 2013 Apr;10(4):610-8;Nucleic Acids Res. 2013 Jun;41(11):5938-48;Nucleic Acids Res. 2013 Aug;41(15):7536-46;PLoS One. 2013 Sep 11;8(9):e74495;Nucleic Acids Res. 2014 Feb;42(4):2736-49;J Bacteriol. 2014 May;196(9):1659-70;RNA Biol. 2014;11(5):563-79;Mol Cell. 2014 Jul 17;55(2):199-213;Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17134-9;Elife. 2014 Dec 31;3:null;Curr Opin Microbiol. 2015 Apr;24:132-9;EMBO J. 2015 Oct 14;34(20):2557-73;Mol Cell. 2016 Feb 4;61(3):352-363;Curr Opin Microbiol. 2016 Apr;30:133-138;EMBO J. 2016 May 2;35(9):991-1011;Mol Cell. 2016 Sep 1;63(5):884-97;Mol Cell. 2017 Jan 5;65(1):39-51;Curr Opin Microbiol. 2018 Apr;42:53-61;MBio. 2018 Sep 25;9(5):;Mol Cancer. 2019 Apr 18;18(1):89;Nature. 1980 Jan 10;283(5743):220-4	PubMed-not-MEDLINE	epublish
5	31069175	2019				Electronic-eCollection	Comparative Study;Journal Article;Research Support, Non-U.S. Gov't	Frontiers in cellular and infection microbiology	Front Cell Infect Microbiol	2235-2988	Human Macrophages Clear the Biovar Microtus Strain of	i	9		111	10.3389/fcimb.2019.00111	Zhang;Xin;Zhao;Liu;Xu;Yan;Kong;Wang;Qi;Zhang;You;Song;Cui;Yang;Zhang;Du	Qingwen;Youquan;Haihong;Rongjiao;Xiaoqing;Yanfeng;Zhipeng;Tong;Zhizhen;Qi;Yang;Yajun;Yujun;Ruifu;Xuefei;Zongmin	Qinghai Institute for Endemic Disease Prevention and Control, Xining, China.;Qinghai Institute for Endemic Disease Prevention and Control, Xining, China.;Qinghai Institute for Endemic Disease Prevention and Control, Xining, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;Qinghai Institute for Endemic Disease Prevention and Control, Xining, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;Qinghai Institute for Endemic Disease Prevention and Control, Xining, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;Qinghai Institute for Endemic Disease Prevention and Control, Xining, China.;Qinghai Institute for Endemic Disease Prevention and Control, Xining, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;Qinghai Institute for Endemic Disease Prevention and Control, Xining, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.	eng	Exp Mol Med. 2007 Aug 31;39(4):421-38;JAMA. 2000 May 3;283(17):2281-90;Mol Biol Cell. 2011 Sep;22(18):3394-409;J Cell Biol. 2002 Aug 5;158(3):401-8;J Immunol. 2004 Jul 15;173(2):1406-16;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;Bioinformatics. 2009 Jul 15;25(14):1754-60;Infect Immun. 1997 Aug;65(8):3412-21;J Immunol. 2006 Feb 1;176(3):1321-5;Genetics. 2005 Oct;171(2):783-90;Genome Biol. 2009;10(3):R25;Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3375-80;Lancet. 2007 Apr 7;369(9568):1196-207;Clin Infect Dis. 2009 Sep 1;49(5):736-42;Nat Protoc. 2009;4(1):44-57;Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31;Infect Immun. 2009 Jan;77(1):367-73;Cell. 2010 Mar 19;140(6):805-20;J Immunol. 1994 May 15;152(10):5070-6;Mol Microbiol. 2004 Jun;52(5):1363-73;Nature. 1979 May 24;279(5711):328-31;Infect Immun. 2009 Jun;77(6):2251-61;Autophagy. 2014 Mar;10(3):416-30;Infect Immun. 2015 Oct 26;84(1):241-53;Infect Immun. 2006 Jul;74(7):3727-41;Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12909-14;J Genet Genomics. 2014 Jul 20;41(7):379-96;Infect Immun. 1999 May;67(5):2225-32;J Interferon Cytokine Res. 2012 Aug;32(8):350-61;J Bacteriol. 2002 Aug;184(16):4601-11;Nat Methods. 2008 Jul;5(7):621-8;PLoS Pathog. 2015 Oct 23;11(10):e1005241;Infect Immun. 2002 Aug;70(8):4092-8;Nature. 2001 Oct 4;413(6855):523-7;J Biol Chem. 2016 May 6;291(19):9894-905;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Clin Microbiol Rev. 1997 Jan;10(1):35-66;DNA Res. 2004 Jun 30;11(3):179-97;Infect Immun. 2006 Jun;74(6):3381-6;J Bacteriol. 2004 Aug;186(15):5147-52;J Proteomics. 2012 Jan 4;75(3):894-907;Int J Med Microbiol. 2017 Jan;307(1):64-74;Nat Genet. 2010 Dec;42(12):1140-3	MEDLINE	epublish
6	30114220	2018	08			Electronic-eCollection	Journal Article;Research Support, Non-U.S. Gov't	PLoS neglected tropical diseases	PLoS Negl Trop Dis	1935-2735	Human plague associated with Tibetan sheep originates in marmots.	The Qinghai-Tibet plateau is a natural plague focus and is the largest such focus in China. In this area, while Marmota himalayana is the primary host, a total of 18 human plague outbreaks associated with Tibetan sheep (78 cases with 47 deaths) have been reported on the Qinghai-Tibet plateau since 1956. All of the index infectious cases had an exposure history of slaughtering or skinning diseased or dead Tibetan sheep. In this study, we sequenced and compared 38 strains of Yersinia pestis isolated from different hosts, including humans, Tibetan sheep, and M. himalayana. Phylogenetic relationships were reconstructed based on genome-wide single-nucleotide polymorphisms identified from our isolates and reference strains. The phylogenetic relationships illustrated in our study, together with the finding that the Tibetan sheep plague clearly lagged behind the M. himalayana plague, and a previous study that identified the Tibetan sheep as a plague reservoir with high susceptibility and moderate sensitivity, indicated that the human plague was transmitted from Tibetan sheep, while the Tibetan sheep plague originated from marmots. Tibetan sheep may encounter this infection by contact with dead rodents or through being bitten by fleas originating from M. himalayana during local epizootics.	12	8	e0006635	10.1371/journal.pntd.0006635	Dai;Wei;Xiong;Yang;Peng;He;Jin;Wang;Zha;Zhang;Liang;Zhang;Xu;Wang;Li	Ruixia;Baiqing;Haoming;Xiaoyan;Yao;Jian;Juan;Yumeng;Xi;Zhikai;Ying;Qingwen;Jianguo;Zuyun;Wei	Qinghai Institute for Endemic Disease Control and Prevention, Xining, China.;Qinghai Institute for Endemic Disease Control and Prevention, Xining, China.;Qinghai Institute for Endemic Disease Control and Prevention, Xining, China.;Qinghai Institute for Endemic Disease Control and Prevention, Xining, China.;National Institute for Communicable Disease Control and Prevention, China CDC, Changping, Beijing, China.;State Key Laboratory of Infectious Disease Prevention and Control, Beijing, China.;Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, Hangzhou, China.;Qinghai Institute for Endemic Disease Control and Prevention, Xining, China.;Qinghai Institute for Endemic Disease Control and Prevention, Xining, China.;National Institute for Communicable Disease Control and Prevention, China CDC, Changping, Beijing, China.;State Key Laboratory of Infectious Disease Prevention and Control, Beijing, China.;Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, Hangzhou, China.;Center for Disease Control and Prevention of Tibet Autonomous Region, Lhasa, China.;National Institute for Communicable Disease Control and Prevention, China CDC, Changping, Beijing, China.;State Key Laboratory of Infectious Disease Prevention and Control, Beijing, China.;Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, Hangzhou, China.;National Institute for Communicable Disease Control and Prevention, China CDC, Changping, Beijing, China.;State Key Laboratory of Infectious Disease Prevention and Control, Beijing, China.;Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, Hangzhou, China.;Qinghai Institute for Endemic Disease Control and Prevention, Xining, China.;National Institute for Communicable Disease Control and Prevention, China CDC, Changping, Beijing, China.;State Key Laboratory of Infectious Disease Prevention and Control, Beijing, China.;Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, Hangzhou, China.;Qinghai Institute for Endemic Disease Control and Prevention, Xining, China.;National Institute for Communicable Disease Control and Prevention, China CDC, Changping, Beijing, China.;State Key Laboratory of Infectious Disease Prevention and Control, Beijing, China.;Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, Hangzhou, China.	eng	Clin Microbiol Rev. 2004 Apr;17(2):434-64;J Bacteriol. 2010 Jul;192(13):3551-2;PLoS One. 2008 Jul 09;3(7):e2652;J Bacteriol. 2006 Jun;188(12):4453-63;J Bacteriol. 2010 Mar;192(6):1685-99;Nature. 2001 Oct 4;413(6855):523-7;Nat Genet. 2010 Dec;42(12):1140-3;Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Mar;36(3):271-4;PLoS One. 2014 Jan 09;9(1):e85374;J Bacteriol. 2002 Aug;184(16):4601-11;Genome Announc. 2015 Apr 30;3(2):null;Adv Exp Med Biol. 2007;603:17-22;Genome Biol. 2004;5(2):R12;Genome Res. 2009 Jun;19(6):1124-32;Ann Trop Med Parasitol. 2005 Dec;99(8):789-93;Genetics. 2007 Mar;175(3):1251-66;Epidemiol Infect. 2011 May;139(5):728-35;J Bacteriol. 2004 Aug;186(15):5147-52;J Wildl Dis. 2008 Oct;44(4):983-7;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;J Infect Dis. 1980 Jun;141(6):724-6	MEDLINE	epublish
7	29887859	2018				Electronic-eCollection	Journal Article	Frontiers in microbiology	Front Microbiol	1664-302X	Phylogeny and Classification of	The established phylogeny of the etiological agent of plague,	9		1106	10.3389/fmicb.2018.01106	Kutyrev;Eroshenko;Motin;Nosov;Krasnov;Kukleva;Nikiforov;Al'khova;Oglodin;Guseva	Vladimir V;Galina A;Vladimir L;Nikita Y;Jaroslav M;Lyubov M;Konstantin A;Zhanna V;Eugene G;Natalia P	Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russia.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russia.;Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States.;Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russia.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russia.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russia.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russia.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russia.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russia.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russia.	eng	Curr Biol. 2017 Dec 4;27(23 ):3683-3691.e8;Genome Announc. 2015 Dec 03;3(6):null;Adv Exp Med Biol. 2016;918:35-78;PLoS One. 2016 Jan 13;11(1):e0145194;Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):577-82;Cell. 2015 Oct 22;163(3):571-82;Lancet Infect Dis. 2014 Apr;14(4):319-26;Genetika. 2016 Sep;52(9):1012-20;Nat Genet. 2010 Dec;42(12):1140-3;Genome Announc. 2015 Sep 17;3(5):null;PLoS One. 2009 Jun 22;4(6):e6000;PLoS Pathog. 2013;9(5):e1003349;Elife. 2016 Jan 21;5:e12994;J Bacteriol. 2002 Feb;184(4):1019-27;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Cell Host Microbe. 2016 Jun 8;19(6):874-81;Adv Exp Med Biol. 2012;954:45-51;Genetika. 2015 Mar;51(3):298-305;Genetika. 2015 Jul;51(7):754-8	PubMed-not-MEDLINE	epublish
8	29073248	2017				Electronic-eCollection	Journal Article	PloS one	PLoS ONE	1932-6203	Yersinia pestis strains of ancient phylogenetic branch 0.ANT are widely spread in the high-mountain plague foci of Kyrgyzstan.	Fifty six Yersinia pestis strains, isolated over the period of more than 50 years in three high-mountain foci of Kyrgyzstan (Tien Shan, Alai, and Talas), have been characterized by means of PCR and single nucleotide polymorphism (SNP) typing methods. Seven of these strains were also characterized by means of whole genome sequencing and genome-wide SNP phylogenetic analysis. It was found that forty two strains belong to 0.ANT2, 0.ANT3 and 0.ANT5 phylogenetic branches. From these, strains of 0.ANT2 and 0.ANT3 branches were earlier detected in China only, whereas 0.ANT5 phylogenetic branch was identified for Y. pestis phylogeny for the first time. According to the results of genome-wide SNP analysis, 0.ANT5 strains are ones of the most closely related to Y. pestis strain responsible for the Justinianic Plague. We have also found out that four of the studied strains belong to the phylogenetic branch 2.MED1, and ten strains from Talas high-mountain focus belong to the phylogenetic branch 0.PE4 (sub-branch 0.PE4t). Established diversity of Y. pestis strains and extensive dissemination of the strains pertaining to the 0.ANT branch confirm the antiquity of the mentioned above plague foci and suggest that strains of the 0.ANT branch, which serve as precursors for all highly virulent Y. pestis strains, had their origin in the Tien Shan mountains.	12	10	e0187230	10.1371/journal.pone.0187230	Eroshenko;Nosov;Krasnov;Oglodin;Kukleva;Guseva;Kuznetsov;Abdikarimov;Dzhaparova;Kutyrev	Galina A;Nikita Yu;Yaroslav M;Yevgeny G;Lyubov M;Natalia P;Alexander A;Sabyrzhan T;Aigul K;Vladimir V	Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russian Federation.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russian Federation.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russian Federation.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russian Federation.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russian Federation.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russian Federation.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russian Federation.;Center for Quarantine and Particularly Dangerous Infections, Department of Disease Prevention of the Ministry of Health of the Kyrgyz Republic, Bishkek, the Kyrgyz Republic.;Center for Quarantine and Particularly Dangerous Infections, Department of Disease Prevention of the Ministry of Health of the Kyrgyz Republic, Bishkek, the Kyrgyz Republic.;Russian Research Anti-Plague Institute "Microbe", Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare, Saratov, Russian Federation.	eng	Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):577-82;Cell. 2015 Oct 22;163(3):571-82;Lancet Infect Dis. 2014 Apr;14(4):319-26;Nat Genet. 2010 Dec;42(12):1140-3;Elife. 2016 Jan 21;5:e12994;J Bacteriol. 2002 Feb;184(4):1019-27;Bull World Health Organ. 1951;4(2):247-63;Cell Host Microbe. 2016 Jun 8;19(6):874-81;Adv Exp Med Biol. 2012;954:45-51;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;Zh Mikrobiol Epidemiol Immunobiol. 2012 May-Jun;(3):25-35;Mol Biol Evol. 2016 Nov;33(11):2911-2923	MEDLINE	epublish
9	28732479	2017	Jul	21		Electronic	Evaluation Study;Journal Article	BMC microbiology	BMC Microbiol.	1471-2180	An integrated computational-experimental approach reveals Yersinia pestis genes essential across a narrow or a broad range of environmental conditions.	The World Health Organization has categorized plague as a re-emerging disease and the potential for Yersinia pestis to also be used as a bioweapon makes the identification of new drug targets against this pathogen a priority. Environmental temperature is a key signal which regulates virulence of the bacterium. The bacterium normally grows outside the human host at 28 °C. Therefore, understanding the mechanisms that the bacterium used to adapt to a mammalian host at 37 °C is central to the development of vaccines or drugs for the prevention or treatment of human disease.;Using a library of over 1 million Y. pestis CO92 random mutants and transposon-directed insertion site sequencing, we identified 530 essential genes when the bacteria were cultured at 28 °C. When the library of mutants was subsequently cultured at 37 °C we identified 19 genes that were essential at 37 °C but not at 28 °C, including genes which encode proteins that play a role in enabling functioning of the type III secretion and in DNA replication and maintenance. Using genome-scale metabolic network reconstruction we showed that growth conditions profoundly influence the physiology of the bacterium, and by combining computational and experimental approaches we were able to identify 54 genes that are essential under a broad range of conditions.;Using an integrated computational-experimental approach we identify genes which are required for growth at 37 °C and under a broad range of environments may be the best targets for the development of new interventions to prevent or treat plague in humans.	17	1	163	10.1186/s12866-017-1073-8	Senior;Sasidharan;Saint;Scott;Sarkar-Tyson;Ireland;Bullifent;Rong Yang;Moore;Oyston;Atkins;Atkins;Soyer;Titball	Nicola J;Kalesh;Richard J;Andrew E;Mitali;Philip M;Helen L;Z;Karen;Petra C F;Timothy P;Helen S;Orkun S;Richard W	College of Life and Environmental Sciences, University of Exeter, Exeter, EX4 4SB, UK.;School of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK.;Defence Science Technology Laboratory, Porton Down, Salisbury, SP4 OJQ, UK.;Defence Science Technology Laboratory, Porton Down, Salisbury, SP4 OJQ, UK.;Defence Science Technology Laboratory, Porton Down, Salisbury, SP4 OJQ, UK.;Marshall Centre for Infectious Disease Research and Training, School of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA, 6009, Australia.;Defence Science Technology Laboratory, Porton Down, Salisbury, SP4 OJQ, UK.;Defence Science Technology Laboratory, Porton Down, Salisbury, SP4 OJQ, UK.;College of Life and Environmental Sciences, University of Exeter, Exeter, EX4 4SB, UK.;College of Life and Environmental Sciences, University of Exeter, Exeter, EX4 4SB, UK.;Defence Science Technology Laboratory, Porton Down, Salisbury, SP4 OJQ, UK.;College of Life and Environmental Sciences, University of Exeter, Exeter, EX4 4SB, UK.;Defence Science Technology Laboratory, Porton Down, Salisbury, SP4 OJQ, UK.;College of Life and Environmental Sciences, University of Exeter, Exeter, EX4 4SB, UK.;Defence Science Technology Laboratory, Porton Down, Salisbury, SP4 OJQ, UK.;School of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK.;College of Life and Environmental Sciences, University of Exeter, Exeter, EX4 4SB, UK. r.w.titball@exeter.ac.uk.	eng	Microb Pathog. 2004 Nov;37(5):241-51;Infect Immun. 2010 Mar;78(3):1304-13;PLoS One. 2013 Jun 07;8(6):e65973;BMC Genomics. 2014 Nov 05;15:958;PLoS One. 2014 Jul 03;9(7):e101869;Gene. 1990 Mar 1;87(1):133-7;Nat Rev Mol Cell Biol. 2002 Oct;3(10):742-52;Antimicrob Agents Chemother. 2006 Oct;50(10):3233-6;Infect Immun. 2009 Jan;77(1):286-91;Genome Biol. 2011 Dec 30;12(12):R127;Nat Rev Microbiol. 2013 Jul;11(7):435-42;PLoS Pathog. 2013;9(7):e1003499;Open Biol. 2012 Dec 05;2(12):120142;Infect Genet Evol. 2016 Jan;37:21-36;Infect Immun. 2009 Feb;77(2):667-75;J Mol Microbiol Biotechnol. 2000 Apr;2(2):225-33;Nature. 2001 Oct 4;413(6855):523-7;Virulence. 2017 Jan 2;8(1):30-40;Expert Opin Ther Targets. 2003 Aug;7(4):469-73;J Biol Chem. 1989 Oct 5;264(28):16403-10;J Biochem. 2001 Jul;130(1):63-71;Mol Microbiol. 2008 Dec;70(5):1062-75;J Bacteriol. 1987 Jan;169(1):19-25;J Bacteriol. 1974 Dec;120(3):1370-9;J Bacteriol. 2002 Aug;184(16):4601-11;Microbiology. 2014 Nov;160(Pt 11):2517-25;J Biol Chem. 2006 Jun 30;281(26):17541-4;Curr Opin Microbiol. 2011 Oct;14(5):544-9;J Bacteriol. 1995 Feb;177(3):517-23;Antimicrob Agents Chemother. 2006 Aug;50(8):2707-12;Clin Microbiol Infect. 2014 Mar;20(3):202-9;Methods Mol Biol. 2015;1279:183-204;Antimicrob Agents Chemother. 2012 Dec;56(12):6223-34;J Bacteriol. 2005 Dec;187(23):8172-80;JAMA. 2000 May 3;283(17):2281-90;Semin Immunol. 2014 Dec;26(6):610-22;J Bacteriol. 1974 Jun;118(3):1020-6;Sci Rep. 2017 Feb 06;7:41923;Infect Immun. 2010 Mar;78(3):1284-93;Infect Immun. 2001 May;69(5):2779-87;Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):934-9;Sci Rep. 2016 Jun 27;6:28684;Genetics. 1988 Nov;120(3):645-50;Infect Immun. 2008 Nov;76(11):5028-37;BMC Syst Biol. 2011 Oct 13;5:163;Microbiology. 2007 Sep;153(Pt 9):3112-24;Mob DNA. 2012 Feb 07;3(1):3;J Bacteriol. 2004 Sep;186(18):6298-305;Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2307-12;Clin Microbiol Rev. 1991 Jul;4(3):309-24;Clin Microbiol Rev. 1997 Jan;10(1):35-66;FEMS Microbiol Lett. 2005 Nov 15;252(2):251-6;Nat Rev Microbiol. 2016 Feb;14 (2):119-28;Front Genet. 2014 Apr 07;5:66;Microbiol Mol Biol Rev. 2008 Dec;72(4):642-71, Table of Contents;Future Med Chem. 2016 Jun;8(10 ):1111-32;J Bacteriol. 2011 Sep;193(18):4582-7;MBio. 2014 Aug 19;5(4):null;J Biol Chem. 2002 Jul 19;277(29):25947-56;Biochim Biophys Acta. 2013 Mar;1827(3):455-69;Nat Protoc. 2010 Jan;5(1):93-121;Proc Natl Acad Sci U S A. 2012 May 1;109(18):E1121-30;Infect Immun. 2014 Apr;82(4):1390-401;J Bacteriol. 2012 Feb;194(3):653-62;Microbiol Immunol. 2004;48(11):791-805;Antimicrob Agents Chemother. 2010 Dec;54(12):4971-7;Mol Microbiol. 2007 Aug;65(3):714-27;PLoS One. 2009 Aug 24;4(8):e6720	MEDLINE	epublish
10	27876297	2017	Jan			Print-Electronic	Journal Article	International journal of medical microbiology : IJMM	Int. J. Med. Microbiol.	1618-0607	Host transcriptomic responses to pneumonic plague reveal that Yersinia pestis inhibits both the initial adaptive and innate immune responses in mice.	Pneumonic plague is the most deadly form of infection caused by Yersinia pestis and can progress extremely fast. However, our understanding on the host transcriptomic response to pneumonic plague is insufficient. Here, we used RNA-sequencing technology to analyze transcriptomic responses in mice infected with fully virulent strain 201 or EV76, a live attenuated vaccine strain lacking the pigmentation locus. Approximately 600 differentially expressed genes (DEGs) were detected in lungs from both 201- and EV76-infected mice at 12h post-infection (hpi). DEGs in lungs of 201-infected mice exceeded 2000 at 48hpi, accompanied by sustained large numbers of DEGs in the liver and spleen; however, limited numbers of DEGs were detected in those organs of EV-infected mice. Remarkably, DEGs in lungs were significantly enriched in critical immune responses pathways in EV76-infected but not 201-infected mice, including antigen processing and presentation, T cell receptor signaling among others. Pathological and bacterial load analyses confirmed the rapid systemic dissemination of 201-infection and the confined EV76-infection in lungs. Our results suggest that fully virulent Y. pestis inhibits both the innate and adaptive immune responses that are substantially stimulated in a self-limited infection, which update our holistic views on the transcriptomic response to pneumonic plague.	307	1	64-74	10.1016/j.ijmm.2016.11.002	Yang;Wang;Tian;Zhang;Wu;Xin;Yan;Tan;Cao;Liu;Cui;Yang;Du	Huiying;Tong;Guang;Qingwen;Xiaohong;Youqian;Yanfeng;Yafang;Shiyang;Wanbing;Yujun;Ruifu;Zongmin	State Key laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.;State Key laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.;State Key laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.;Key Laboratory for Plague Prevention and Control of Qinghai Province, Qinghai Institute for Endemic Disease Prevention and Control of Qinghai Province, Xining 811602, China.;State Key laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.;Key Laboratory for Plague Prevention and Control of Qinghai Province, Qinghai Institute for Endemic Disease Prevention and Control of Qinghai Province, Xining 811602, China.;State Key laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.;State Key laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.;State Key laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.;State Key laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.;State Key laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.;State Key laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China. Electronic address: ruifuyang@gmail.com.;State Key laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China. Electronic address: zmduams@163.com.	eng		MEDLINE	ppublish
11	26634751	2015	Dec	03		Electronic	Journal Article	Genome announcements	Genome Announc	2169-8287	Nineteen Whole-Genome Assemblies of Yersinia pestis subsp. microtus, Including Representatives of Biovars caucasica, talassica, hissarica, altaica, xilingolensis, and ulegeica.	The etiologic agent of plague, Yersinia pestis, includes two subspecies, of which Y. pestis subsp. microtus contains the strains that cause only occasional diseases in humans that are not accompanied by human-to-human transmission. Here, we report the draft genome sequences of 19 Y. pestis strains (across 6 biovars of Y. pestis subsp. microtus).	3	6		10.1128/genomeA.01342-15	Kislichkina;Bogun;Kadnikova;Maiskaya;Platonov;Anisimov;Galkina;Dentovskaya;Anisimov	Angelina A;Aleksandr G;Lidiya A;Nadezhda V;Mikhail E;Nikolai V;Elena V;Svetlana V;Andrey P	State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russia angelinakislichkina@yandex.ru anisimov@obolensk.org.;State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russia.;State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russia.;State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russia.;State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russia.;State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russia.;State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russia.;State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russia.;State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russia angelinakislichkina@yandex.ru anisimov@obolensk.org.	eng	Clin Microbiol Rev. 2004 Apr;17(2):434-64;PLoS One. 2012;7(2):e30624;Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):577-82	PubMed-not-MEDLINE	epublish
12	26599979	2015				Electronic-eCollection	Journal Article;Research Support, U.S. Gov't, Non-P.H.S.	PloS one	PLoS ONE	1932-6203	Investigation of Yersinia pestis Laboratory Adaptation through a Combined Genomics and Proteomics Approach.	The bacterial pathogen Yersinia pestis, the cause of plague in humans and animals, normally has a sylvatic lifestyle, cycling between fleas and mammals. In contrast, laboratory-grown Y. pestis experiences a more constant environment and conditions that it would not normally encounter. The transition from the natural environment to the laboratory results in a vastly different set of selective pressures, and represents what could be considered domestication. Understanding the kinds of adaptations Y. pestis undergoes as it becomes domesticated will contribute to understanding the basic biology of this important pathogen. In this study, we performed a parallel serial passage experiment (PSPE) to explore the mechanisms by which Y. pestis adapts to laboratory conditions, hypothesizing that cells would undergo significant changes in virulence and nutrient acquisition systems. Two wild strains were serially passaged in 12 independent populations each for ~750 generations, after which each population was analyzed using whole-genome sequencing, LC-MS/MS proteomic analysis, and GC/MS metabolomics. We observed considerable parallel evolution in the endpoint populations, detecting multiple independent mutations in ail, pepA, and zwf, suggesting that specific selective pressures are shaping evolutionary responses. Complementary LC-MS/MS proteomic data provide physiological context to the observed mutations, and reveal regulatory changes not necessarily associated with specific mutations, including changes in amino acid metabolism and cell envelope biogenesis. Proteomic data support hypotheses generated by genomic data in addition to suggesting future mechanistic studies, indicating that future whole-genome sequencing studies be designed to leverage proteomics as a critical complement.	10	11	e0142997	10.1371/journal.pone.0142997	Leiser;Merkley;Clowers;Deatherage Kaiser;Lin;Hutchison;Melville;Wagner;Keim;Foster;Kreuzer	Owen P;Eric D;Brian H;Brooke L;Andy;Janine R;Angela M;David M;Paul S;Jeffrey T;Helen W	Center for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, AZ, 86001, United States of America.;Chemical and Biological Signature Sciences, Pacific Northwest National Laboratory, Richland, WA, 99352, United States of America.;Department of Chemistry, Washington State University, Pullman, WA, 99354, United States of America.;Chemical and Biological Signature Sciences, Pacific Northwest National Laboratory, Richland, WA, 99352, United States of America.;Chemical and Biological Signature Sciences, Pacific Northwest National Laboratory, Richland, WA, 99352, United States of America.;Chemical and Biological Signature Sciences, Pacific Northwest National Laboratory, Richland, WA, 99352, United States of America.;Chemical and Biological Signature Sciences, Pacific Northwest National Laboratory, Richland, WA, 99352, United States of America.;Center for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, AZ, 86001, United States of America.;Center for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, AZ, 86001, United States of America.;Center for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, AZ, 86001, United States of America.;Chemical and Biological Signature Sciences, Pacific Northwest National Laboratory, Richland, WA, 99352, United States of America.	eng	J Mol Biol. 2000 Sep 15;302(2):411-26;Mutat Res. 2007 Mar 1;616(1-2):145-58;Cell. 1995 Nov 17;83(4):577-87;Biochim Biophys Acta. 2011 Jan;1808(1):482-9;BMC Syst Biol. 2011;5:163;Environ Microbiol. 2014 Mar;16(3):813-28;FEBS Lett. 2007 Aug 7;581(20):3771-6;Proteomics. 2008 Apr;8(7):1442-58;Mol Biol Evol. 1992 May;9(3):394-402;BMC Genomics. 2008;9:75;Mol Microbiol. 2005 Aug;57(4):927-41;J Clin Microbiol. 1993 Jun;31(6):1511-4;J Biol Chem. 1998 May 1;273(18):11032-7;Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S323-6;Nucleic Acids Res. 2014 Jan;42(Database issue):D206-14;Mol Microbiol. 1992 Sep;6(18):2693-704;J Bacteriol. 2006 Jun;188(12):4453-63;J Bacteriol. 2010 Oct;192(19):4801-11;Front Cell Infect Microbiol. 2012;2:103;Lancet Infect Dis. 2014 Apr;14(4):319-26;Annu Rev Microbiol. 2003;57:155-76;Nature. 2001 Oct 4;413(6855):523-7;Nucleic Acids Res. 2014 Jan;42(Database issue):D231-9;Biotechnol Bioeng. 2004 Aug 20;87(4):485-94;Mol Microbiol. 2004 Apr;52(1):53-65;Metab Eng. 2004 Apr;6(2):164-74;Nat Genet. 2010 Dec;42(12):1140-3;Mol Cell Proteomics. 2014 Sep;13(9):2513-26;Mem Inst Oswaldo Cruz. 2004 Nov;99(7):727-32;Anal Chem. 2006 Nov 15;78(22):7796-801;J Proteome Res. 2006 Nov;5(11):3008-17;Free Radic Biol Med. 2014 Jan;66:75-87;Immunity. 2010 Feb 26;32(2):279-89;J Microbiol Methods. 2002 Sep;51(1):95-104;J Cell Sci. 2005 Oct 1;118(Pt 19):4327-32;BMC Microbiol. 2010;10:30;J Med Entomol. 2007 May;44(3):530-7;J Bacteriol. 2001 Nov;183(22):6538-42;Infect Immun. 1998 Oct;66(10):4611-23;Nat Rev Microbiol. 2005 May;3(5):371-82;Nat Protoc. 2012 Jul;7(7):1260-84;Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4321-6;Microb Ecol. 2000 Aug;40(2):75-84;Microbiol Rev. 1978 Jun;42(2):307-28;PLoS Genet. 2014 Dec;10(12):e1004872;Vet Microbiol. 2011 May 12;150(1-2):146-51;Mol Biosyst. 2013 Jan 27;9(1):44-54;J Proteome Res. 2010 Jul 2;9(7):3647-55;Mol Microbiol. 2001 Jan;39(1):199-210;Plasmid. 2004 Jul;52(1):63-8;J Bacteriol. 2006 May;188(9):3236-45;Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31;Genome Res. 2009 Jun;19(6):1117-23;J Bacteriol. 1989 May;171(5):2689-96;J Bacteriol. 2008 May;190(9):3169-75;J Proteome Res. 2011 Apr 1;10(4):1794-805;J Mol Biol. 1990 Oct 5;215(3):403-10;J Med Entomol. 2003 May;40(3):329-37;J Mol Biol. 1995 Jul 21;250(4):392-406;Nat Biotechnol. 2008 Dec;26(12):1367-72;EMBO J. 1999 Aug 16;18(16):4513-22;Microbiology. 2007 Sep;153(Pt 9):3112-24;J Microbiol Methods. 2010 Jul;82(1):95-7;Annu Rev Entomol. 2005;50:505-28;Genetics. 2015 Jun;200(2):619-31;Biochemistry. 2006 Jan 10;45(1):20-33;Curr Opin Microbiol. 2008 Dec;11(6):535-40;Genome Biol. 2004;5(2):R12;PLoS One. 2010;5(7):e11556;Nat Biotechnol. 2014 Mar;32(3):223-6;Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8408-13;J Bacteriol. 1998 Oct;180(19):5192-202;J Microbiol Methods. 2015 May;112:3-10;Clin Microbiol Rev. 1997 Jan;10(1):35-66;Genes Dev. 2007 Oct 1;21(19):2473-84;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;Int J Med Microbiol. 2011 Feb;301(2):105-16;Bioinformatics. 2008 Jul 1;24(13):1556-8;Proteome Sci. 2009 Feb 19;7:5;Curr Opin Struct Biol. 2010 Apr;20(2):253-8;Mol Cell. 2011 Mar 18;41(6):625-35;Infect Immun. 1986 Feb;51(2):445-54;Microbiology. 2009 Feb;155(Pt 2):498-512;Infect Immun. 2001 Jan;69(1):170-6;Microbiol Rev. 1986 Sep;50(3):314-52;EMBO J. 2004 Nov 10;23(22):4434-42	MEDLINE	epublish
13	26463167	2015	Oct	13		Electronic	Journal Article;Research Support, N.I.H., Extramural	mBio	mBio	2150-7511	Spatially distinct neutrophil responses within the inflammatory lesions of pneumonic plague.	During pneumonic plague, the bacterium Yersinia pestis elicits the development of inflammatory lung lesions that continue to expand throughout infection. This lesion development and persistence are poorly understood. Here, we examine spatially distinct regions of lung lesions using laser capture microdissection and transcriptome sequencing (RNA-seq) analysis to identify transcriptional differences between lesion microenvironments. We show that cellular pathways involved in leukocyte migration and apoptosis are downregulated in the center of lung lesions compared to the periphery. Probing for the bacterial factor(s) important for the alteration in neutrophil survival, we show both in vitro and in vivo that Y. pestis increases neutrophil survival in a manner that is dependent on the type III secretion system effector YopM. This research explores the complexity of spatially distinct host-microbe interactions and emphasizes the importance of cell relevance in assays in order to fully understand Y. pestis virulence.;Yersinia pestis is a high-priority pathogen and continues to cause outbreaks worldwide. The ability of Y. pestis to be transmitted via respiratory droplets and its history of weaponization has led to its classification as a select agent most likely to be used as a biological weapon. Unrestricted bacterial growth during the initial preinflammatory phase primes patients to be infectious once disease symptoms begin in the proinflammatory phase, and the rapid disease progression can lead to death before Y. pestis infection can be diagnosed and treated. Using in vivo analyses and focusing on relevant cell types during pneumonic plague infection, we can identify host pathways that may be manipulated to extend the treatment window for pneumonic plague patients.	6	5	e01530-15	10.1128/mBio.01530-15	Stasulli;Eichelberger;Price;Pechous;Montgomery;Parker;Goldman	Nikolas M;Kara R;Paul A;Roger D;Stephanie A;Joel S;William E	Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.;Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.;Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.;Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.;Department of Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.;Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.;Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA goldman@med.unc.edu.	eng	Infect Immun. 1986 Apr;52(1):285-92;Trends Immunol. 2010 Aug;31(8):318-24;PLoS Pathog. 2013;9(10):e1003679;Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50;Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4335-9;Infect Immun. 2008 Aug;76(8):3754-60;MBio. 2014;5(4):e01402-14;Plasmid. 1981 Mar;5(2):183-7;Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13514-9;J Exp Med. 2004 Mar 1;199(5):687-95;J Bacteriol. 2004 Jul;186(13):4056-66;Microbes Infect. 2003 Nov;5(14):1337-44;Infect Immun. 2011 Feb;79(2):674-87;Science. 2007 Jan 26;315(5811):509-13;Thromb Haemost. 2007 Sep;98(3):521-9;Cell Microbiol. 2006 Sep;8(9):1406-16;Microbiology. 2006 May;152(Pt 5):1327-35;Infect Immun. 2010 Aug;78(8):3529-39;J Leukoc Biol. 2011 May;89(5):675-83;Infect Immun. 2010 Jul;78(7):2946-55;Front Plant Sci. 2013 May 09;4:135;Am J Pathol. 2009 Mar;174(3):910-21;Annu Rev Immunol. 2005;23:197-223;PLoS Med. 2008 Jan 15;5(1):e3;Science. 1996 Jul 19;273(5273):367-70;Microbes Infect. 2009 Feb;11(2):205-14;Am J Hematol. 2008 Apr;83(4):288-95;Nat Med. 2012 Sep;18(9):1386-93;Comp Med. 2008 Feb;58(1):68-75;Nat Rev Microbiol. 2003 Oct;1(1):55-64;J Cell Death. 2014 May 08;7:15-23;Bioinformatics. 2009 Aug 15;25(16):2078-9;J Med Primatol. 2011 Feb;40(1):6-17;J Innate Immun. 2013;5(2):124-36;Science. 1996 Nov 8;274(5289):998-1001;J Biol Chem. 2003 May 16;278(20):18514-23;J Immunol. 2012 Apr 1;188(7):3351-63;MBio. 2013;4(5):e00170-13;Infect Immun. 2012 Jul;80(7):2519-27;JAMA. 2000 May 3;283(17):2281-90;Infect Immun. 1988 Oct;56(10):2749-52;Planta. 2007 Nov;226(6):1389-409;Nucleic Acids Res. 2010 Oct;38(18):e178;Am J Respir Cell Mol Biol. 2010 Jul;43(1):5-16;Science. 2004 Mar 5;303(5663):1532-5;PLoS Pathog. 2015 May;11(5):e1004893;PLoS One. 2010;5(10). pii: e13165. doi: 10.1371/journal.pone.0013165;Front Cell Infect Microbiol. 2012;2:143;BMC Bioinformatics. 2011;12:323;Infect Immun. 1995 Jul;63(7):2570-5;PLoS One. 2014;9(1):e87859;Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17786-91;Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3083-8;Mol Plant Microbe Interact. 2007 Sep;20(9):1055-62;EMBO J. 2011 May 18;30(10):1977-89;Science. 2005 Sep 9;309(5741):1739-41;Am J Pathol. 1968 Jul;53(1):99-114;J Immunol. 2014 Jan 1;192(1):234-44;Infect Immun. 2009 Feb;77(2):568-75;Adv Exp Med Biol. 2012;954:253-60;Infect Immun. 2010 May;78(5):2045-52;Biotechniques. 1999 Feb;26(2):328-35;Plant Mol Biol. 2005 Dec;59(6):965-79;Cell Host Microbe. 2014 Apr 9;15(4):424-34;Annu Rev Microbiol. 2005;59:69-89;Clin Vaccine Immunol. 2012 Apr;19(4):468-76;Infect Immun. 2005 Dec;73(12):8209-18;Front Immunol. 2013 Mar 06;4:60;Infect Immun. 2013 Nov;81(11):4041-52;Clin Microbiol Rev. 1997 Jan;10(1):35-66;Infect Immun. 2002 Aug;70(8):4165-76;Cell Host Microbe. 2015 Jan 14;17(1):21-31;Infect Immun. 2005 Nov;73(11):7142-50;Cell Microbiol. 2006 Nov;8(11):1687-96;J Biol Chem. 2007 May 11;282(19):14056-64;PLoS One. 2010;5(2):e9279;Infect Immun. 2009 Sep;77(9):3791-806;PLoS One. 2014;9(11):e110956;Cell Host Microbe. 2012 Dec 13;12(6):799-805;Biochem J. 2007 Jan 1;401(1):29-38;Infect Immun. 1990 Oct;58(10):3262-71;Infect Immun. 1991 Nov;59(11):4255-8;Microbes Infect. 2010 Apr;12(4):331-5;J Periodontol. 1982 Aug;53(8):502-8;BMC Bioinformatics. 2010;11:94;J Infect Dis. 2012 Oct 1;206(7):1050-8;Infect Immun. 2010 Jun;78(6):2584-98;Infect Immun. 2004 Aug;72(8):4589-602;Plant Signal Behav. 2008 Feb;3(2):105-7;Eur J Clin Invest. 2012 Dec;42(12):1342-9;Br J Exp Pathol. 1956 Dec;37(6):570-6;Infect Immun. 2002 Mar;70(3):1453-60;Cell Microbiol. 2008 Mar;10(3):557-65	MEDLINE	epublish
14	26383663	2015	Sep	17		Electronic	Journal Article	Genome announcements	Genome Announc	2169-8287	Genome Assemblies for 11 Yersinia pestis Strains Isolated in the Caucasus Region.	Yersinia pestis, the causative agent of plague, is endemic to the Caucasus region but few reference strain genome sequences from that region are available. Here, we present the improved draft or finished assembled genomes from 11 strains isolated in the nation of Georgia and surrounding countries.	3	5		10.1128/genomeA.01030-15	Zhgenti;Johnson;Davenport;Chanturia;Daligault;Chain;Nikolich	Ekaterine;Shannon L;Karen W;Gvantsa;Hajnalka E;Patrick S;Mikeljon P	National Center for Disease Control and Public Health (NCDC), Tbilisi, Georgia.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA shannonj@lanl.gov.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;National Center for Disease Control and Public Health (NCDC), Tbilisi, Georgia.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;Walter Reed Army Institute of Research (WRAIR), Silver Spring, Maryland, USA.	eng	Clin Microbiol Rev. 2004 Apr;17(2):434-64;Clin Microbiol Infect. 2008 May;14(5):429-36;Genome Res. 2008 May;18(5):810-20;Genome Res. 1998 Mar;8(3):195-202;Nat Methods. 2013 Jun;10(6):563-9;Genome Res. 2008 May;18(5):821-9;Genome Res. 1998 Mar;8(3):186-94;Pharmacogenomics. 2004 Jun;5(4):433-8;Science. 2009 Jan 2;323(5910):133-8;Annu Rev Entomol. 2005;50:505-28;Nature. 2005 Sep 15;437(7057):376-80;Genome Res. 1998 Mar;8(3):175-85	PubMed-not-MEDLINE	epublish
15	26383662	2015	Sep	17		Electronic	Journal Article	Genome announcements	Genome Announc	2169-8287	Finished Genome Assembly of Yersinia pestis EV76D and KIM 10v.	Here, we sequenced the completed genome of Yersinia pestis EV76D and KIM 10v, two genomes used as references in assay development, to improved high-quality draft status.	3	5		10.1128/genomeA.01024-15	Johnson;Minogue;Daligault;Wolcott;Teshima;Coyne;Davenport;Jaissle;Chain	Shannon L;Timothy D;Hajnalka E;Mark J;Hazuki;Susan R;Karen W;James G;Patrick S	Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;United States Army Medical Research Institute for Infectious Diseases (USAMRIID), Frederick, Maryland, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;United States Army Medical Research Institute for Infectious Diseases (USAMRIID), Frederick, Maryland, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;United States Army Medical Research Institute for Infectious Diseases (USAMRIID), Frederick, Maryland, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;United States Army Medical Research Institute for Infectious Diseases (USAMRIID), Frederick, Maryland, USA shannonj@lanl.gov.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.	eng	Genome Res. 2008 May;18(5):810-20;Genome Res. 2008 May;18(5):821-9;Genome Res. 1998 Mar;8(3):186-94;J Bacteriol. 2002 Aug;184(16):4601-11;Pharmacogenomics. 2004 Jun;5(4):433-8;Nature. 2005 Sep 15;437(7057):376-80;Genome Res. 1998 Mar;8(3):175-85	PubMed-not-MEDLINE	epublish
16	25931590	2015	Apr	30		Electronic	Journal Article	Genome announcements	Genome Announc	2169-8287	Thirty-Two Complete Genome Assemblies of Nine Yersinia Species, Including Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica.	The genus Yersinia includes three human pathogens, of which Yersinia pestis is responsible for >2,000 illnesses each year. To aid in the development of detection assays and aid further phylogenetic elucidation, we sequenced and assembled the complete genomes of 32 strains (across 9 Yersinia species).	3	2		10.1128/genomeA.00148-15	Johnson;Daligault;Davenport;Jaissle;Frey;Ladner;Broomall;Bishop-Lilly;Bruce;Coyne;Gibbons;Lo;Munk;Rosenzweig;Koroleva;Palacios;Redden;Xu;Minogue;Chain	Shannon L;Hajnalka E;Karen W;James;Kenneth G;Jason T;Stacey M;Kimberly A;David C;Susan R;Henry S;Chien-Chi;A Christine;C Nicole;Galina I;Gustavo F;Cassie L;Yan;Timothy D;Patrick S	Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA shannonj@lanl.gov.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Diagnostic Systems Division (DSD), Fort Detrick, Maryland, USA.;Center for Genome Sciences (CGS), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.;United States Army Edgewood Chemical Biological Center (ECBC), Aberdeen Proving Ground, Aberdeen, Maryland, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Diagnostic Systems Division (DSD), Fort Detrick, Maryland, USA.;United States Army Edgewood Chemical Biological Center (ECBC), Aberdeen Proving Ground, Aberdeen, Maryland, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;United States Army Edgewood Chemical Biological Center (ECBC), Aberdeen Proving Ground, Aberdeen, Maryland, USA.;Center for Genome Sciences (CGS), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.;Center for Genome Sciences (CGS), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Diagnostic Systems Division (DSD), Fort Detrick, Maryland, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.	eng	Genome Res. 2008 May;18(5):810-20;Genome Res. 1998 Mar;8(3):195-202;Nat Methods. 2013 Jun;10(6):563-9;J AOAC Int. 2011 Jul-Aug;94(4):1342-6;Clin Med Res. 2006 Sep;4(3):189-99;Genome Res. 1998 Mar;8(3):186-94;JAMA. 2000 May 3;283(17):2281-90;Proc (Bayl Univ Med Cent). 2005 Apr;18(2):116-24;Bioinformatics. 2010 Apr 15;26(8):1122-4;Clin Microbiol Rev. 1997 Jan;10(1):35-66;Genome Res. 1998 Mar;8(3):175-85;Science. 2009 Oct 9;326(5950):236-7	PubMed-not-MEDLINE	epublish
17	25342679	2014	Oct	23		Electronic	Journal Article	Genome announcements	Genome Announc	2169-8287	Whole-Genome Yersinia sp. Assemblies from 10 Diverse Strains.	Yersinia spp. are animal pathogens, some of which cause human disease. We sequenced 10 Yersinia isolates (from six species: Yersinia enterocolitica, Y. fredericksenii, Y. kristensenii, Y. pestis, Y. pseudotuberculosis, and Y. ruckeri) to high-quality draft or complete status. The genomes range in size from 3.77 to 4.94 Mbp.	2	5		10.1128/genomeA.01055-14	Daligault;Davenport;Minogue;Bishop-Lilly;Broomall;Bruce;Chain;Coyne;Frey;Gibbons;Jaissle;Koroleva;Ladner;Lo;Munk;Palacios;Redden;Rosenzweig;Scholz;Johnson	H E;K W;T D;K A;S M;D C;P S;S R;K G;H S;J;G I;J T;C-C;C;G F;C L;C N;M B;S L	Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;Diagnostic Systems Division (DSD), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.;United States Army Edgewood Chemical Biological Center (ECBC), Aberdeen Proving Ground, Aberdeen, Maryland, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;Diagnostic Systems Division (DSD), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.;United States Army Edgewood Chemical Biological Center (ECBC), Aberdeen Proving Ground, Aberdeen, Maryland, USA.;Diagnostic Systems Division (DSD), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.;Center for Genome Sciences (CGS), USAMRIID, Fort Detrick, Maryland, USA.;Center for Genome Sciences (CGS), USAMRIID, Fort Detrick, Maryland, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;Center for Genome Sciences (CGS), USAMRIID, Fort Detrick, Maryland, USA.;Center for Genome Sciences (CGS), USAMRIID, Fort Detrick, Maryland, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.;Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA shannonj@lanl.gov.	eng	Genome Res. 2008 May;18(5):810-20;Genome Res. 1998 Mar;8(3):195-202;Genome Res. 2008 May;18(5):821-9;Genome Res. 1998 Mar;8(3):186-94;Pharmacogenomics. 2004 Jun;5(4):433-8;Lancet. 2007 Apr 7;369(9568):1196-207;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Clin Microbiol Rev. 1997 Jan;10(1):35-66;Nature. 2005 Sep 15;437(7057):376-80;Genome Res. 1998 Mar;8(3):175-85	PubMed-not-MEDLINE	epublish
18	25320451	2014	Dec			Print-Electronic	Journal Article	Indian journal of microbiology	Indian J. Microbiol.	0046-8991	Draft Genome Sequences of Yersinia pestis Strains from the 1994 Plague Epidemic of Surat and 2002 Shimla Outbreak in India.	We report the first draft genome sequences of the strains of plague-causing bacteria, Yersinia pestis, from India. These include two strains from the Surat epidemic (1994), one strain from the Shimla outbreak (2002) and one strain from the plague surveillance activity in the Deccan plateau region (1998). Genome size for all four strains is ~4.49 million bp with 139-147 contigs. Average sequencing depth for all four genomes was 21x.	54	4	480-2	10.1007/s12088-014-0475-7	Mahale;Paranjape;Marathe;Dhotre;Chowdhury;Shetty;Sharma;Sharma;Tuteja;Batra;Shouche	Kiran N;Pradyumna S;Nachiket P;Dhiraj P;Somak;Sudarshan A;Avinash;Kaushal;Urmil;Harsh V;Yogesh S	Microbial Culture Collection, National Centre for Cell Science, University of Pune Campus, GaneshKhind, Pune, 411007 Maharashtra India.;Microbial Culture Collection, National Centre for Cell Science, University of Pune Campus, GaneshKhind, Pune, 411007 Maharashtra India.;Microbial Culture Collection, National Centre for Cell Science, University of Pune Campus, GaneshKhind, Pune, 411007 Maharashtra India.;Microbial Culture Collection, National Centre for Cell Science, University of Pune Campus, GaneshKhind, Pune, 411007 Maharashtra India.;Microbial Culture Collection, National Centre for Cell Science, University of Pune Campus, GaneshKhind, Pune, 411007 Maharashtra India.;Microbial Culture Collection, National Centre for Cell Science, University of Pune Campus, GaneshKhind, Pune, 411007 Maharashtra India.;Microbial Culture Collection, National Centre for Cell Science, University of Pune Campus, GaneshKhind, Pune, 411007 Maharashtra India.;Microbial Culture Collection, National Centre for Cell Science, University of Pune Campus, GaneshKhind, Pune, 411007 Maharashtra India.;Microbiology Division, Defence Research and Development Establishment, Gwalior, Madhya Pradesh India.;Microbiology Division, Defence Food Research Laboratory, Mysore, Karnataka India.;Microbial Culture Collection, National Centre for Cell Science, University of Pune Campus, GaneshKhind, Pune, 411007 Maharashtra India.	eng	Antonie Van Leeuwenhoek. 2009 Oct;96(3):303-12;Annu Rev Entomol. 2012;57:61-82;BMC Genomics. 2008 Feb 08;9:75;Annu Rev Entomol. 2005;50:505-28;Clin Microbiol Rev. 1997 Jan;10(1):35-66;BMJ. 1994 Oct 8;309(6959):893-4;BMJ. 1994 Nov 19;309(6965):1369	PubMed-not-MEDLINE	ppublish
19	24807359	2014	Jul			Print-Electronic	Case Reports;Journal Article;Research Support, Non-U.S. Gov't	Journal of wildlife diseases	J. Wildl. Dis.	1943-3700	Sylvatic plague in a Canadian black-tailed prairie dog (Cynomys ludovicianus).	In 2010, a black-tailed prairie dog (Cynomys ludovicianus) was found dead in Grasslands National Park, Saskatchewan, Canada. Postmortem gross and histologic findings indicated bacterial septicemia, likely due to Yersinia pestis, which was confirmed by molecular analysis. This is the first report of Y. pestis in the prairie dog population within Canada.	50	3	699-702	10.7589/2013-08-215	Antonation;Shury;Bollinger;Olson;Mabon;Van Domselaar;Corbett	Kym S;Todd K;Trent K;Adam;Philip;Gary;Cindi R	1  Bioforensics Assay Development and Diagnostics, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington St., Winnipeg, Manitoba, R3E 3R2, Canada.	eng		MEDLINE	ppublish
20	24416399	2014				Electronic-eCollection	Journal Article;Research Support, Non-U.S. Gov't	PloS one	PLoS ONE	1932-6203	Two-step source tracing strategy of Yersinia pestis and its historical epidemiology in a specific region.	Source tracing of pathogens is critical for the control and prevention of infectious diseases. Genome sequencing by high throughput technologies is currently feasible and popular, leading to the burst of deciphered bacterial genome sequences. Utilizing the flooding genomic data for source tracing of pathogens in outbreaks is promising, and challenging as well. Here, we employed Yersinia pestis genomes from a plague outbreak at Xinghai county of China in 2009 as an example, to develop a simple two-step strategy for rapid source tracing of the outbreak. The first step was to define the phylogenetic position of the outbreak strains in a whole species tree, and the next step was to provide a detailed relationship across the outbreak strains and their suspected relatives. Through this strategy, we observed that the Xinghai plague outbreak was caused by Y. pestis that circulated in the local plague focus, where the majority of historical plague epidemics in the Qinghai-Tibet Plateau may originate from. The analytical strategy developed here will be of great help in fighting against the outbreaks of emerging infectious diseases, by pinpointing the source of pathogens rapidly with genomic epidemiological data and microbial forensics information.	9	1	e85374	10.1371/journal.pone.0085374	Yan;Wang;Li;Yang;Wang;Qi;Zhang;Cui;Guo;Yu;Wang;Wang;Liu;Song;Li;Cui;Yang	Yanfeng;Hu;Dongfang;Xianwei;Zuyun;Zhizhen;Qingwen;Baizhong;Zhaobiao;Chang;Jun;Jian;Guangming;Yajun;Yingrui;Yujun;Ruifu	State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China ; BGI-Shenzhen, Shenzhen, China.;Qinghai Institute for Endemic Diseases Prevention and Control, Xining, China.;BGI-Shenzhen, Shenzhen, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;Qinghai Institute for Endemic Diseases Prevention and Control, Xining, China.;Qinghai Institute for Endemic Diseases Prevention and Control, Xining, China.;Qinghai Institute for Endemic Diseases Prevention and Control, Xining, China.;Qinghai Institute for Endemic Diseases Prevention and Control, Xining, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;BGI-Shenzhen, Shenzhen, China.;BGI-Shenzhen, Shenzhen, China.;BGI-Shenzhen, Shenzhen, China.;School of Computer Science, National University of Defense Technology, Changsha, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.;BGI-Shenzhen, Shenzhen, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China ; BGI-Shenzhen, Shenzhen, China.;State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China ; BGI-Shenzhen, Shenzhen, China.	eng	Annu Rev Microbiol. 2008;62:53-70;Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13536-41;Nat Genet. 2008 Aug;40(8):987-93;N Engl J Med. 2011 Feb 24;364(8):730-9;Microbes Infect. 2006 Jan;8(1):273-84;J Bacteriol. 2004 Aug;186(15):5138-46;Wkly Epidemiol Rec. 2003 Apr 18;78(16):130-5;Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):577-82;Emerg Infect Dis. 2004 Jan;10(1):117-20;Science. 2010 Jan 22;327(5964):469-74;Clin Infect Dis. 2011 Jan 15;52(2):185-90;Nat Genet. 2010 Dec;42(12):1140-3;J Clin Microbiol. 2001 Dec;39(12):4566-7;BMC Biol. 2009;7:78;Sci Transl Med. 2012 Aug 22;4(148):148ra116;Emerg Infect Dis. 2005 Sep;11(9):1494-6;Syst Biol. 2003 Oct;52(5):696-704;Lancet. 2007 Apr 7;369(9568):1196-207;PLoS One. 2008;3(7):e2652;Emerg Infect Dis. 2009 Oct;15(10):1623-5;PLoS One. 2009;4(11):e7815;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Brief Bioinform. 2008 Jul;9(4):299-306;Genome Biol. 2004;5(2):R12;Science. 2002 Jun 14;296(5575):2028-33;Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8408-13;N Engl J Med. 2011 Aug 25;365(8):718-24;PLoS One. 2009;4(6):e6000;PLoS One. 2008;3(5):e2166;Clin Microbiol Rev. 1997 Jan;10(1):35-66;N Engl J Med. 2012 Jun 14;366(24):2267-75;Bioinformatics. 2005 Feb 15;21(4):456-63;Int J Legal Med. 2005 Nov;119(6):317-30;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;Bioinformatics. 2008 Mar 1;24(5):713-4;Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7527-32;PLoS One. 2013 Jun 21;8(6):e66567;Science. 2005 Apr 1;308(5718):31;Genome Res. 2010 Feb;20(2):265-72	MEDLINE	epublish
21	23521061	2013	Jun			Print-Electronic	Journal Article;Research Support, Non-U.S. Gov't	FEMS microbiology letters	FEMS Microbiol. Lett.	1574-6968	A strain of Yersinia pestis with a mutator phenotype from the Republic of Georgia.	We describe here a strain of Yersinia pestis, G1670A, which exhibits a baseline mutation rate elevated 250-fold over wild-type Y. pestis. The responsible mutation, a C to T substitution in the mutS gene, results in the transition of a highly conserved leucine at position 689 to arginine (mutS(L689R)). When the MutSL 689R protein of G1670A was expressed in a ΔmutS derivative of Y. pestis strain EV76, mutation rates observed were equivalent to those observed in G1670A, consistent with a causal association between the mutS mutation and the mutator phenotype. The observation of a mutator allele in Yersinia pestis has potential implications for the study of evolution of this and other especially dangerous pathogens.	343	2	113-20	10.1111/1574-6968.12137	Rajanna;Ouellette;Rashid;Zemla;Karavis;Zhou;Revazishvili;Redmond;McNew;Bakanidze;Imnadze;Rivers;Skowronski;O'Connell;Sulakvelidze;Gibbons	Chythanya;Gary;Mohammed;Adam;Mark;Carol;Tamara;Brady;Lauren;Lela;Paata;Bryan;Evan W;Kevin P;Alexander;Henry S	Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.	eng		MEDLINE	ppublish
22	23469360	2013	Jan			Print-Electronic	Journal Article	Genome announcements	Genome Announc	2169-8287	Whole-Genome Sequencing and Comparative Analysis of Yersinia pestis, the Causative Agent of a Plague Outbreak in Northern Peru.	The plague is a zoonotic disease caused by the bacterium	1	1		10.1128/genomeA.00249-12	Cáceres;Montenegro;Padilla;Tarazona;Bailón;García;Céspedes;Valencia;Guio	O;J;C;D;H;P;M;P;H	Laboratorio de Biotecnología y Biología Molecular, Instituto Nacional de Salud, Lima, Peru.	eng	Bioinformatics. 2005 May 1;21(9):2083-4;Investig Genet. 2010 Sep 01;1(1):5;Nat Methods. 2012 Mar 04;9(4):357-9;Nature. 2001 Oct 4;413(6855):523-7;Nat Genet. 2010 Dec;42(12):1140-3;J Bacteriol. 2002 Aug;184(16):4601-11;Bioinformatics. 2009 Aug 15;25(16):2078-9;BMC Genomics. 2011 Aug 08;12:402;Nucleic Acids Res. 1995 Dec 25;23(24):4992-9;BMC Genomics. 2008 Feb 08;9:75;J Bacteriol. 2002 Feb;184(4):1019-27;Nucleic Acids Res. 2005 Feb 17;33(3):1040-50	Publisher	ppublish
23	23271803	2013	Jan	08		Print-Electronic	Journal Article;Research Support, Non-U.S. Gov't	Proceedings of the National Academy of Sciences of the United States of America	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	Historical variations in mutation rate in an epidemic pathogen, Yersinia pestis.	The genetic diversity of Yersinia pestis, the etiologic agent of plague, is extremely limited because of its recent origin coupled with a slow clock rate. Here we identified 2,326 SNPs from 133 genomes of Y. pestis strains that were isolated in China and elsewhere. These SNPs define the genealogy of Y. pestis since its most recent common ancestor. All but 28 of these SNPs represented mutations that happened only once within the genealogy, and they were distributed essentially at random among individual genes. Only seven genes contained a significant excess of nonsynonymous SNP, suggesting that the fixation of SNPs mainly arises via neutral processes, such as genetic drift, rather than Darwinian selection. However, the rate of fixation varies dramatically over the genealogy: the number of SNPs accumulated by different lineages was highly variable and the genealogy contains multiple polytomies, one of which resulted in four branches near the time of the Black Death. We suggest that demographic changes can affect the speed of evolution in epidemic pathogens even in the absence of natural selection, and hypothesize that neutral SNPs are fixed rapidly during intermittent epidemics and outbreaks.	110	2	577-82	10.1073/pnas.1205750110	Cui;Yu;Yan;Li;Li;Jombart;Weinert;Wang;Guo;Xu;Zhang;Zheng;Qin;Xiao;Wu;Wang;Zhou;Qi;Du;Wu;Yang;Cao;Wang;Wang;Yao;Rakin;Li;Falush;Balloux;Achtman;Song;Wang;Yang	Yujun;Chang;Yanfeng;Dongfang;Yanjun;Thibaut;Lucy A;Zuyun;Zhaobiao;Lizhi;Yujiang;Hancheng;Nan;Xiao;Mingshou;Xiaoyi;Dongsheng;Zhizhen;Zongmin;Honglong;Xianwei;Hongzhi;Hu;Jing;Shusen;Alexander;Yingrui;Daniel;Francois;Mark;Yajun;Jun;Ruifu	State Key Laboratory of Pathogen and Biosecurity,  Beijing Institute of Microbiology and Epidemiology, Beijing 100071,  China.	eng	Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Genome Res. 2010 Feb;20(2):265-72;J Bacteriol. 2004 Aug;186(15):5147-52;DNA Res. 2004 Jun 30;11(3):179-97;Emerg Infect Dis. 2004 Sep;10(9):1585-92;Nature. 1969 Oct 11;224(5215):149-54;Am J Phys Anthropol. 2005 Jan;126(1):48-55;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;Annu Rev Entomol. 2005;50:505-28;J Infect Dis. 2005 Jun 1;191(11):1907-12;Mol Biol Evol. 2005 Jul;22(7):1561-8;Curr Issues Mol Biol. 2005 Jul;7(2):197-212;Emerg Infect Dis. 2005 Aug;11(8):1317-8; author reply 1318-9;Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13950-5;J Bacteriol. 2010 Mar;192(6):1685-99;PLoS Pathog. 2010 Apr;6(4):e1000855;BMC Biol. 2010;8:114;PLoS Pathog. 2010;6(10):e1001134;Nat Genet. 2010 Dec;42(12):1140-3;PLoS Genet. 2011 Feb;7(2):e1001301;PLoS One. 2011;6(3):e16735;Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10214-9;Nature. 2011 Oct 27;478(7370):506-10;Environ Microbiol. 2011 Dec;13(12):3114-27;Appl Environ Microbiol. 2011 Dec;77(24):8648-55;Lancet Infect Dis. 2006 Apr;6(4):234-41;PLoS Biol. 2006 May;4(5):e88;Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13110-5;Syst Biol. 2006 Aug;55(4):637-43;Science. 2006 Nov 24;314(5803):1301-4;Mol Microbiol. 2007 Feb;63(4):1145-57;Emerg Infect Dis. 2007 Feb;13(2):332-3;PLoS Med. 2008 Jan 15;5(1):e3;BMC Evol Biol. 2007;7:214;PLoS One. 2008;3(5):e2166;Nat Genet. 2008 Aug;40(8):987-93;Annu Rev Microbiol. 2008;62:53-70;Microbiology. 2009 Jan;155(Pt 1):198-209;Science. 2009 Jan 16;323(5912):379-82;PLoS Genet. 2009 Jan;5(1):e1000344;PLoS One. 2009;4(6):e6000;Nature. 2009 Jun 25;459(7250):1122-5;Nat Rev Microbiol. 2009 Nov;7(11):813-21;Nature. 2009 Oct 29;461(7268):1243-7;J Bacteriol. 2009 Dec;191(24):7628-9;Science. 2010 Jan 22;327(5964):469-74;Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8408-13	MEDLINE	ppublish
24	23133618	2012				Print-Electronic	Journal Article;Research Support, U.S. Gov't, Non-P.H.S.	PloS one	PLoS ONE	1932-6203	Genomic comparison of Escherichia coli O104:H4 isolates from 2009 and 2011 reveals plasmid, and prophage heterogeneity, including shiga toxin encoding phage stx2.	In May of 2011, an enteroaggregative Escherichia coli O104:H4 strain that had acquired a Shiga toxin 2-converting phage caused a large outbreak of bloody diarrhea in Europe which was notable for its high prevalence of hemolytic uremic syndrome cases. Several studies have described the genomic inventory and phylogenies of strains associated with the outbreak and a collection of historical E. coli O104:H4 isolates using draft genome assemblies. We present the complete, closed genome sequences of an isolate from the 2011 outbreak (2011C-3493) and two isolates from cases of bloody diarrhea that occurred in the Republic of Georgia in 2009 (2009EL-2050 and 2009EL-2071). Comparative genome analysis indicates that, while the Georgian strains are the nearest neighbors to the 2011 outbreak isolates sequenced to date, structural and nucleotide-level differences are evident in the Stx2 phage genomes, the mer/tet antibiotic resistance island, and in the prophage and plasmid profiles of the strains, including a previously undescribed plasmid with homology to the pMT virulence plasmid of Yersinia pestis. In addition, multiphenotype analysis showed that 2009EL-2071 possessed higher resistance to polymyxin and membrane-disrupting agents. Finally, we show evidence by electron microscopy of the presence of a common phage morphotype among the European and Georgian strains and a second phage morphotype among the Georgian strains. The presence of at least two stx2 phage genotypes in host genetic backgrounds that may derive from a recent common ancestor of the 2011 outbreak isolates indicates that the emergence of stx2 phage-containing E. coli O104:H4 strains probably occurred more than once, or that the current outbreak isolates may be the result of a recent transfer of a new stx2 phage element into a pre-existing stx2-positive genetic background.	7	11	e48228	10.1371/journal.pone.0048228	Ahmed;Awosika;Baldwin;Bishop-Lilly;Biswas;Broomall;Chain;Chertkov;Chokoshvili;Coyne;Davenport;Detter;Dorman;Erkkila;Folster;Frey;George;Gleasner;Henry;Hill;Hubbard;Insalaco;Johnson;Kitzmiller;Krepps;Lo;Luu;McNew;Minogue;Munk;Osborne;Patel;Reitenga;Rosenzweig;Shea;Shen;Strockbine;Tarr;Teshima;van Gieson;Verratti;Wolcott;Xie;Sozhamannan;Gibbons	Sanaa A;Joy;Carson;Kimberly A;Biswajit;Stacey;Patrick S G;Olga;Otar;Susan;Karen;J Chris;William;Tracy H;Jason P;Kenneth G;Matroner;Cheryl;Matthew;Karen K;Kyle;Joseph;Shannon;Aaron;Michael;Chien-Chi;Truong;Lauren A;Timothy;Christine A;Brian;Mohit;Krista G;C Nicole;April;Xiaohong;Nancy;Cheryl;Hazuki;Eric;Kathleen;Mark;Gary;Shanmuga;Henry S	Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.	eng	Bioinformatics. 2006 Nov 1;22(21):2688-90;Bioinformatics. 2009 Apr 1;25(7):962-3;Nat Rev Microbiol. 2004 Feb;2(2):123-40;Appl Environ Microbiol. 2012 Mar;78(5):1601-5;Mol Microbiol. 2011 Jun;80(6):1420-38;Infect Immun. 1999 May;67(5):2184-92;Clin Infect Dis. 2007 Nov 15;45(10):1353-61;Genome Res. 1998 Mar;8(3):195-202;Int J Food Microbiol. 2012 Feb 15;153(3):388-94;Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3065-70;J Bacteriol. 2011 Sep;193(17):4509-15;Nucleic Acids Res. 2002 Jun 1;30(11):2478-83;Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1664-8;BMC Genomics. 2008;9:75;Pediatr Nephrol. 2002 Apr;17(4):293-8;Infect Immun. 2003 Aug;71(8):4554-62;PLoS Biol. 2005 Jul;3(7):e229;ISME J. 2011 Apr;5(4):613-26;PLoS One. 2011;6(7):e22751;J Bacteriol. 2002 Jan;184(1):302-6;Genome Res. 2008 May;18(5):821-9;Am Fam Physician. 2006 Sep 15;74(6):991-6;Euro Surveill. 2011;16(24). pii: 19889;PLoS One. 2012;7(5):e37362;Annu Rev Phytopathol. 2006;44:367-92;Infect Immun. 2012 Mar;80(3):903-13;Genome Res. 1998 Mar;8(3):186-94;Nucleic Acids Res. 2006;34(20):5839-51;Infect Immun. 1999 Dec;67(12):6710-4;J Anim Sci. 2007 Mar;85(13 Suppl):E45-62;Microbiology. 2004 Jan;150(Pt 1):61-72;Microbiology. 2001 Jul;147(Pt 7):1929-36;J Food Prot. 2001 Nov;64(11):1817-9;BMC Bioinformatics. 2011;12:109;J Food Prot. 2009 Nov;72(11):2308-12;Nucleic Acids Res. 2002 Jul 15;30(14):3059-66;Pharmacogenomics. 2004 Jun;5(4):433-8;PLoS One. 2010;5(3):e9490;J Clin Microbiol. 2002 Aug;40(8):3086-8;Emerg Infect Dis. 2008 Aug;14(8):1287-90;Annu Rev Microbiol. 2011;65:455-78;Appl Environ Microbiol. 2012 Mar;78(5):1615-8;J Virol. 2012 Oct;86(19):10444-55;J Bacteriol. 2012 Jan;194(2):532-3;N Engl J Med. 2011 Aug 25;365(8):709-17;BMC Genomics. 2012;13:311;Arch Microbiol. 2011 Dec;193(12):883-91;Antimicrob Agents Chemother. 2010 Nov;54(11):4914-6;J Mol Biol. 1990 Oct 5;215(3):403-10;Infect Immun. 1997 Oct;65(10):4135-45;Nature. 1990 Aug 30;346(6287):871-4;Cell. 1997 Nov 14;91(4):511-20;Toxins (Basel). 2010 Dec 2;2(12):2769-2794;PLoS One. 2009;4(8):e6532;Infect Immun. 1992 Jun;60(6):2297-304;Genome Biol. 2004;5(2):R12;Nucleic Acids Res. 2002 Apr 1;30(7):1575-84;Infect Immun. 2009 Jun;77(6):2465-73;ISME J. 2011 Feb;5(2):173-83;N Engl J Med. 2011 Aug 25;365(8):718-24;J Bacteriol. 1995 Mar;177(5):1247-53;Infect Immun. 1994 Nov;62(11):5183-6;Mol Microbiol. 2003 Sep;49(5):1309-20;Infect Immun. 2001 Mar;69(3):1231-43;Euro Surveill. 2011;16(26). pii: 19905;Mol Microbiol. 2005 Jan;55(2):425-40;Environ Microbiol. 2010 Sep;12(9):2385-97;Infect Immun. 1996 Feb;64(2):495-502;Antimicrob Agents Chemother. 2009 Dec;53(12):5046-54;Microbiol Mol Biol Rev. 2004 Sep;68(3):560-602, table of contents;Antimicrob Agents Chemother. 2010 May;54(5):2269-70;Appl Environ Microbiol. 2007 Dec;73(24):8032-40;Clin Infect Dis. 2006 Dec 15;43(12):1587-95;Infect Immun. 2006 Aug;74(8):4486-95;Int J Food Microbiol. 2006 Aug 15;111(1):1-5;Nature. 2005 Sep 15;437(7057):376-80;J Bacteriol. 1999 Apr;181(7):2257-60;Genome Res. 1998 Mar;8(3):175-85;Science. 2009 Oct 9;326(5950):236-7;PLoS One. 2010;5(9). pii: e12714. doi: 10.1371/journal.pone.0012714;Nature. 2001 Oct 25;413(6858):848-52;Bioinformatics. 2008 Dec 1;24(23):2672-6;Lancet Infect Dis. 2011 Sep;11(9):671-6	MEDLINE	ppublish
25	22965078	2012	Oct			Print	Journal Article;Research Support, Non-U.S. Gov't	Journal of bacteriology	J. Bacteriol.	1098-5530	Draft genome sequence of Yersinia pestis strain 2501, an isolate from the great gerbil plague focus in Xinjiang, China.	We deciphered the genome of Yersinia pestis strain 2501, isolated from the Junggar Basin, a newly discovered great gerbil plague focus in Xinjiang, China. The total length of assembly was 4,597,322 bp, and 4,265 coding sequences were predicted within the genome. It is the first Y. pestis genome from this plague focus.	194	19	5447-8	10.1128/JB.01150-12	Sun;Yang;Yuan;Dai;Yan;Cao;Luo;Guo;Wang;Song;Yang;Zhang;Cui	Surong;Xianwei;Yanting;Xiang;Yanfeng;Hanli;Tao;Rong;Xinhui;Yajun;Ruifu;Yujiang;Yujun	Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, People's Republic of China.	eng	Clin Microbiol Rev. 2004 Apr;17(2):434-64;Wkly Epidemiol Rec. 2004 Aug 13;79(33):301-6;Clin Microbiol Rev. 1997 Jan;10(1):35-66;Bioinformatics. 2007 Mar 15;23(6):673-9;PLoS Med. 2008 Jan 15;5(1):e3;BMC Biol. 2010;8:112;PLoS One. 2008;3(7):e2652;Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Feb;29(2):136-44;PLoS One. 2009;4(6):e6000;Genome Res. 2010 Feb;20(2):265-72;PLoS One. 2008;3(5):e2166	MEDLINE	ppublish
26	22359605	2012				Print-Electronic	Comparative Study;Journal Article;Research Support, Non-U.S. Gov't;Research Support, U.S. Gov't, Non-P.H.S.	PloS one	PLoS ONE	1932-6203	Comparative genomics of 2009 seasonal plague (Yersinia pestis) in New Mexico.	Plague disease caused by the gram-negative bacterium Yersinia pestis routinely affects animals and occasionally humans, in the western United States. The strains native to the North American continent are thought to be derived from a single introduction in the late 19(th) century. The degree to which these isolates have diverged genetically since their introduction is not clear, and new genomic markers to assay the diversity of North American plague are highly desired. To assay genetic diversity of plague isolates within confined geographic areas, draft genome sequences were generated by 454 pyrosequencing from nine environmental and clinical plague isolates. In silico assemblies of Variable Number Tandem Repeat (VNTR) loci were compared to laboratory-generated profiles for seven markers. High-confidence SNPs and small Insertion/Deletions (Indels) were compared to previously sequenced Y. pestis isolates. The resulting panel of mutations allowed clustering of the strains and tracing of the most likely evolutionary trajectory of the plague strains. The sequences also allowed the identification of new putative SNPs that differentiate the 2009 isolates from previously sequenced plague strains and from each other. In addition, new insertion points for the abundant insertion sequences (IS) of Y. pestis are present that allow additional discrimination of strains; several of these new insertions potentially inactivate genes implicated in virulence. These sequences enable whole-genome phylogenetic analysis and allow the unbiased comparison of closely related isolates of a genetically monomorphic pathogen.	7	2	e31604	10.1371/journal.pone.0031604	Gibbons;Krepps;Ouellette;Karavis;Onischuk;Leonard;Broomall;Sickler;Betters;McGregor;Donarum;Liem;Fochler;McNew;Rosenzweig;Skowronski	Henry S;Michael D;Gary;Mark;Lisa;Pascale;Stacey;Todd;Janet L;Paul;Greg;Alvin;Ed;Lauren;C Nicole;Evan	United States Army Edgewood Chemical Biological Center, Aberdeen Proving Ground, Maryland, United States of America. henry.gibbons.civ@mail.mil	eng	Clin Microbiol Rev. 2004 Apr;17(2):434-64;Mutat Res. 2007 Mar 1;616(1-2):145-58;PLoS Pathog. 2010 Oct 07;6(10):e1001134;PLoS One. 2007 Feb 21;2(2):e220;Public Health Monogr. 1955;26:1-120;BMC Microbiol. 2004 Jun 08;4:22;BMC Microbiol. 2001;1:2;Emerg Infect Dis. 2008 Jun;14(6):941-3;Nature. 2001 Oct 4;413(6855):523-7;JAMA. 1997 Aug 6;278(5):389-95;Evolution. 1985 Jul;39(4):783-791;Nat Genet. 2010 Dec;42(12):1140-3;Nature. 2011 Oct 12;478(7370):506-10;PLoS One. 2011 Mar 10;6(3):e16735;Microbiology. 2008 Sep;154(Pt 9):2865-71;Infect Immun. 2001 Dec;69(12 ):7810-9;Adv Exp Med Biol. 2007;603:17-22;J Clin Microbiol. 2001 Sep;39(9):3179-85;Lancet Infect Dis. 2006 Apr;6(4):234-41;Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5027-32;PLoS One. 2007 Aug 22;2(8):e770;Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8408-13;Microbiology. 2009 Jan;155(Pt 1):198-209;Emerg Infect Dis. 2007 Feb;13(2):332-3;Clin Microbiol Rev. 1997 Jan;10(1):35-66;Infect Immun. 1999 Aug;67(8):3879-92;Am J Trop Med Hyg. 1994 Jul;51(1):109-14;Infect Immun. 2000 Aug;68(8):4523-30;Mol Biol Evol. 2007 Aug;24(8):1596-9;Emerg Infect Dis. 2004 Sep;10(9):1585-92	MEDLINE	ppublish
27	21993626	2011	Oct	12		Electronic	Historical Article;Journal Article;Research Support, Non-U.S. Gov't	Nature	Nature	1476-4687	A draft genome of Yersinia pestis from victims of the Black Death.	Technological advances in DNA recovery and sequencing have drastically expanded the scope of genetic analyses of ancient specimens to the extent that full genomic investigations are now feasible and are quickly becoming standard. This trend has important implications for infectious disease research because genomic data from ancient microbes may help to elucidate mechanisms of pathogen evolution and adaptation for emerging and re-emerging infections. Here we report a reconstructed ancient genome of Yersinia pestis at 30-fold average coverage from Black Death victims securely dated to episodes of pestilence-associated mortality in London, England, 1348-1350. Genetic architecture and phylogenetic analysis indicate that the ancient organism is ancestral to most extant strains and sits very close to the ancestral node of all Y. pestis commonly associated with human infection. Temporal estimates suggest that the Black Death of 1347-1351 was the main historical event responsible for the introduction and widespread dissemination of the ancestor to all currently circulating Y. pestis strains pathogenic to humans, and further indicates that contemporary Y. pestis epidemics have their origins in the medieval era. Comparisons against modern genomes reveal no unique derived positions in the medieval organism, indicating that the perceived increased virulence of the disease during the Black Death may not have been due to bacterial phenotype. These findings support the notion that factors other than microbial genetics, such as environment, vector dynamics and host susceptibility, should be at the forefront of epidemiological discussions regarding emerging Y. pestis infections.	478	7370	506-10	10.1038/nature10549	Bos;Schuenemann;Golding;Burbano;Waglechner;Coombes;McPhee;DeWitte;Meyer;Schmedes;Wood;Earn;Herring;Bauer;Poinar;Krause	Kirsten I;Verena J;G Brian;Hernán A;Nicholas;Brian K;Joseph B;Sharon N;Matthias;Sarah;James;David J D;D Ann;Peter;Hendrik N;Johannes	McMaster Ancient DNA Centre, Department of Anthropology, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8, Canada.	eng	DNA Res. 2004 Jun 30;11(3):179-97;Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):E746-52;Nature. 1994 Jan 27;367(6461):384-6;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;PLoS Pathog. 2006 May;2(5):e42;Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14616-21;PLoS Med. 2008 Jan 15;5(1):e3;Cell. 2008 Aug 8;134(3):416-26;Infect Immun. 2008 Oct;76(10):4592-9;Nat Protoc. 2009;4(6):960-74;J Bacteriol. 2009 Dec;191(24):7628-9;Science. 2010 Jan 22;327(5964):469-74;Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31;Nat Rev Genet. 2011 Sep;12(9):603-14;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Nature. 2000 Oct 19;407(6806):903-6;Hum Biol. 2003 Aug;75(4):427-48;Med Anthropol Q. 2003 Dec;17(4):423-41;Early Sci Med. 2003;8(3):253-66;PLoS Pathog. 2010;6(10):e1001134;Nat Genet. 2010 Dec;42(12):1140-3;Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10214-9	MEDLINE	epublish
28	21559501	2011	Apr	29		Electronic	Journal Article;Research Support, N.I.H., Extramural	PloS one	PLoS ONE	1932-6203	Genome sequencing and analysis of Yersina pestis KIM D27, an avirulent strain exempt from select agent regulation.	Yersinia pestis is the causative agent of the plague. Y. pestis KIM 10+ strain was passaged and selected for loss of the 102 kb pgm locus, resulting in an attenuated strain, KIM D27. In this study, whole genome sequencing was performed on KIM D27 in order to identify any additional differences. Initial assemblies of 454 data were highly fragmented, and various bioinformatic tools detected between 15 and 465 SNPs and INDELs when comparing both strains, the vast majority associated with A or T homopolymer sequences. Consequently, Illumina sequencing was performed to improve the quality of the assembly. Hybrid sequence assemblies were performed and a total of 56 validated SNP/INDELs and 5 repeat differences were identified in the D27 strain relative to published KIM 10+ sequence. However, further analysis showed that 55 of these SNP/INDELs and 3 repeats were errors in the KIM 10+ reference sequence. We conclude that both 454 and Illumina sequencing were required to obtain the most accurate and rapid sequence results for Y. pestis KIMD27. SNP and INDELS calls were most accurate when both Newbler and CLC Genomics Workbench were employed. For purposes of obtaining high quality genome sequence differences between strains, any identified differences should be verified in both the new and reference genomes.	6	4	e19054	10.1371/journal.pone.0019054	Losada;Varga;Hostetler;Radune;Kim;Durkin;Schneewind;Nierman	Liliana;John J;Jessica;Diana;Maria;Scott;Olaf;William C	J. Craig Venter Institute, Rockville, Maryland, United States of America. llosada@jcvi.org	eng	Gene. 1997 Jul 1;193(1):13-21;Bioinformatics. 2008 Dec 15;24(24):2818-24;Microbiology. 2006 Nov;152(Pt 11):3399-410;PLoS One. 2008;3(4):e2058;Curr Protoc Microbiol. 2008 Nov;Chapter 5:Unit 5B.2;J Bacteriol. 2010 Jan;192(2):560-7;PLoS One. 2010;5(8):e12397;Nat Genet. 2010 Dec;42(12):1140-3;Nucleic Acids Res. 1999 Jan 15;27(2):573-80;J Mol Biol. 2004 Jul 16;340(4):783-95;Proc Int Conf Intell Syst Mol Biol. 2000;8:228-38;J Bacteriol. 2002 Aug;184(16):4601-11;Infect Immun. 1998 Dec;66(12):5755-62;Infect Immun. 1999 Sep;67(9):4851-61;J Bacteriol. 1969 Jun;98(3):1404-6;J Clin Microbiol. 2010 Aug;48(8):2821-9;Microbes Infect. 2001 Jun;3(7):561-9;Am J Pathol. 1968 Jul;53(1):99-114;Brief Bioinform. 2004 Sep;5(3):237-48;PLoS One. 2010;5(7):e11556;Science. 2002 Jun 14;296(5575):2028-33;Genome Biol. 2009;10(10):R118;Bioinformatics. 1999 May;15(5):426-7;Genome Biol Evol. 2010 Jan 22;2:102-16;PLoS Genet. 2008;4(7):e1000128;PLoS One. 2009;4(12):e8240;Nature. 2005 Sep 15;437(7057):376-80;Infect Immun. 1993 Jun;61(6):2717-22	MEDLINE	epublish
29	20943893	2011	Jan			Print-Electronic	Journal Article;Research Support, Non-U.S. Gov't	The Journal of general virology	J. Gen. Virol.	1465-2099	The complete genome sequence and proteomics of Yersinia pestis phage Yep-phi.	Yep-phi, a lytic phage of Yersinia pestis, was isolated in China and is routinely used as a diagnostic phage for the identification of the plague pathogen. Yep-phi has an isometric hexagonal head containing dsDNA and a short non-contractile conical tail. In this study, we sequenced the Yep-phi genome (GenBank accession no. HQ333270) and performed proteomics analysis. The genome consists of 38 ,616 bp of DNA, including direct terminal repeats of 222 bp, and is predicted to contain 45 ORFs. Most structural proteins were identified by proteomics analysis. Compared with the three available genome sequences of lytic phages for Y. pestis, the phages could be divided into two subgroups. Yep-phi displays marked homology to the bacteriophages Berlin (GenBank accession no. AM183667) and Yepe2 (GenBank accession no. EU734170), and these comprise one subgroup. The other subgroup is represented by bacteriophage ΦA1122 (GenBank accession no. AY247822). Potential recombination was detected among the Yep-phi subgroup.	92	Pt 1	216-21	10.1099/vir.0.026328-0	Zhao;Wu;Qi;Cui;Yan;Guo;Wang;Wang;Deng;Xue;Chen;Wang;Yang	Xiangna;Weili;Zhizhen;Yujun;Yanfeng;Zhaobiao;Zuyun;Hu;Haijun;Yan;Weijun;Xiaoyi;Ruifu	State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, PR China.	eng		MEDLINE	ppublish
30	20584081	2010	Aug	01		Print-Electronic	Journal Article	FEMS microbiology letters	FEMS Microbiol. Lett.	1574-6968	New plasmids and putative virulence factors from the draft genome of an Australian clinical isolate of Photorhabdus asymbiotica.	Clinical isolates of Photorhabdus asymbiotica have been recovered from patients in both the United States of America and Australia, and the full sequence of P. asymbiotica ATCC43949 from the United States has been reported recently. In contrast to other bacteria in the genus that only infect insects, P. asymbiotica strains are able to infect both insects and humans. Using a combination of Solexa (Illumina) and 454 Life Sciences (Roche) sequence data in different assembly pipelines, we report on a draft genome sequence of a strain of P. asymbiotica recovered from a patient from Kingscliff, Australia. The best assembly yielded an N50 scaffold size of 288 627 base pairs (bp) with >88.6% of the predicted genome covered by scaffolds over 100 000 bp. One of the central differences found between this Australian isolate and the US isolate is the presence of an additional plasmid, pPAA3. This plasmid is similar to pCRY from Yersinia pestis, the causative agent of bubonic plague, and the presence of pPAA3 may account for the increased virulence of Australian isolates both against tissue culture cells and infected patients. The genome of the Kingscliff strain also contains several genomic differences from the US isolate, whose potential significance in virulence against both humans and insects is discussed.	309	2	136-43	10.1111/j.1574-6968.2010.02030.x	Wilkinson;Paszkiewicz;Moorhouse;Szubert;Beatson;Gerrard;Waterfield;Ffrench-Constant	Paul;Konrad;Alex;Jan M;Scott;John;Nicholas R;Richard H	School of Biosciences, University of Exeter in Cornwall, Penryn, UK.	eng		MEDLINE	ppublish
31	20453098	2010	Jul			Print-Electronic	Journal Article;Research Support, Non-U.S. Gov't	Journal of bacteriology	J. Bacteriol.	1098-5530	Complete genome sequences of Yersinia pestis from natural foci in China.	Yersinia pestis, the causative agent of plague, is a deadly bacterium that affects humans. Strain D106004 was isolated from a new plague focus in Yulong County, China, in 2006. To gain insights into the epidemic origin, we have sequenced the genomes of D106004 and strains Z176003 and D182038, isolated from neighboring regions.	192	13	3551-2	10.1128/JB.00340-10	Shen;Wang;Xia;Zhu;Zhang;Liang;Cai;Zhang;Wei;Chen;Song;Zhang;Yu;Hai	Xiaona;Qi;Lianxu;Xiaoyu;Zhikai;Ying;Hong;Enmin;Jianchun;Chen;Zhizhong;Hongtao;Dongzheng;Rong	State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.	eng	Nucleic Acids Res. 1997 Mar 1;25(5):955-64;Nucleic Acids Res. 1998 Jan 15;26(2):544-8;J Bacteriol. 2006 Jun;188(12):4453-63;PLoS One. 2007;2(2):e220;PLoS One. 2007;2(8):e770;Am J Trop Med Hyg. 2009 Oct;81(4):714-7;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Nature. 2001 Oct 4;413(6855):523-7;J Bacteriol. 2002 Aug;184(16):4601-11;J Bacteriol. 2003 May;185(9):2759-73;DNA Res. 2004 Jun 30;11(3):179-97;J Clin Microbiol. 2010 May;48(5):1619-23;BMC Microbiol. 2009;9:205	MEDLINE	ppublish
32	20061468	2010	Mar			Print-Electronic	Journal Article;Research Support, N.I.H., Extramural;Research Support, U.S. Gov't, Non-P.H.S.	Journal of bacteriology	J. Bacteriol.	1098-5530	Genome sequence of the deep-rooted Yersinia pestis strain Angola reveals new insights into the evolution and pangenome of the plague bacterium.	To gain insights into the origin and genome evolution of the plague bacterium Yersinia pestis, we have sequenced the deep-rooted strain Angola, a virulent Pestoides isolate. Its ancient nature makes this atypical isolate of particular importance in understanding the evolution of plague pathogenicity. Its chromosome features a unique genetic make-up intermediate between modern Y. pestis isolates and its evolutionary ancestor, Y. pseudotuberculosis. Our genotypic and phenotypic analyses led us to conclude that Angola belongs to one of the most ancient Y. pestis lineages thus far sequenced. The mobilome carries the first reported chimeric plasmid combining the two species-specific virulence plasmids. Genomic findings were validated in virulence assays demonstrating that its pathogenic potential is distinct from modern Y. pestis isolates. Human infection with this particular isolate would not be diagnosed by the standard clinical tests, as Angola lacks the plasmid-borne capsule, and a possible emergence of this genotype raises major public health concerns. To assess the genomic plasticity in Y. pestis, we investigated the global gene reservoir and estimated the pangenome at 4,844 unique protein-coding genes. As shown by the genomic analysis of this evolutionary key isolate, we found that the genomic plasticity within Y. pestis clearly was not as limited as previously thought, which is strengthened by the detection of the largest number of isolate-specific single-nucleotide polymorphisms (SNPs) currently reported in the species. This study identified numerous novel genetic signatures, some of which seem to be intimately associated with plague virulence. These markers are valuable in the development of a robust typing system critical for forensic, diagnostic, and epidemiological studies.	192	6	1685-99	10.1128/JB.01518-09	Eppinger;Worsham;Nikolich;Riley;Sebastian;Mou;Achtman;Lindler;Ravel	Mark;Patricia L;Mikeljon P;David R;Yinong;Sherry;Mark;Luther E;Jacques	Institute for Genome Sciences and Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, Maryland 21201, USA.	eng	J Bacteriol. 2009 Dec;191(24):7628-9;Int J Med Microbiol. 2004 Apr;293(7-8):453-61;PLoS One. 2007;2(2):e220;Clin Microbiol Rev. 2004 Apr;17(2):434-64;DNA Res. 2004 Jun 30;11(3):179-97;PLoS Pathog. 2009 Mar;5(3):e1000346;Nucleic Acids Res. 2002 Jun 1;30(11):2478-83;Science. 2007 Jan 26;315(5811):509-13;PLoS Genet. 2009 Jan;5(1):e1000344;PLoS Genet. 2007 Aug;3(8):e142;Arch Pathol Lab Med. 1996 Feb;120(2):156-63;J Bacteriol. 2006 Jun;188(12):4453-63;Bull Soc Pathol Exot Filiales. 1965 Mar-Apr;58(2):154-6;Nature. 2001 Oct 4;413(6855):523-7;N Engl J Med. 1997 Sep 4;337(10):677-80;Infect Immun. 2009 May;77(5):1807-16;J Bacteriol. 2004 Mar;186(5):1484-92;Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W557-9;Infect Immun. 2009 Jun;77(6):2242-50;Mem Inst Oswaldo Cruz. 2004 Nov;99(7):727-32;J Clin Microbiol. 2000 Apr;38(4):1516-9;J Bacteriol. 2009 Aug;191(15):4758-66;J Bacteriol. 2002 Aug;184(16):4601-11;J Mol Evol. 1985;22(2):160-74;Nat Rev Microbiol. 2003 Oct;1(1):55-64;Mol Gen Mikrobiol Virusol. 2008;(2):23-7;Curr Opin Genet Dev. 2005 Dec;15(6):589-94;Schweiz Z Pathol Bakteriol. 1953;16(3):509-14;Am J Physiol. 1947 Jul 1;150(1):70-7;FEMS Microbiol Lett. 1990 Jan 15;55(1-2):45-8;J Clin Microbiol. 2006 Jun;44(6):2084-92;PLoS One. 2007;2(8):e770;Adv Exp Med Biol. 2007;603:17-22;BMC Bioinformatics. 2005;6:2;Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31;Adv Exp Med Biol. 2007;603:74-87;J Bacteriol. 2002 Feb;184(4):1019-27;Contrib Microbiol Immunol. 1995;13:299-305;J Bacteriol. 2002 Nov;184(21):6050-5;PLoS Genet. 2006 Dec 15;2(12):e206;Am J Trop Med Hyg. 1998 Nov;59(5):679-86;Nature. 1957 Jun 15;179(4572):1246-7;Chem Pharm Bull (Tokyo). 1993 Feb;41(2):362-8;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;BMC Microbiol. 2004 Mar 4;4:9;Am J Public Health. 1978 Mar;68(3):262-4;PLoS One. 2007;2(3):e309;Genome Biol. 2004;5(2):R12;Mol Microbiol. 1993 Jun;8(6):1031-8;PLoS One. 2009;4(6):e6000;PLoS One. 2008;3(5):e2166;Microbiology. 2009 Jan;155(Pt 1):198-209;Bull World Health Organ. 1960;23:408-9;Epidemiol Infect. 1988 Aug;101(1):59-73;Infect Immun. 1996 Nov;64(11):4580-5;J Bacteriol. 2004 Aug;186(15):5147-52;Infect Immun. 2004 Oct;72(10):5613-21;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;J Bacteriol. 2007 Jul;189(14):4984-93;PLoS Genet. 2008;4(7):e1000128;Nature. 1999 May 27;399(6734):323-9;PLoS One. 2008;3(3):e1800;Clin Infect Dis. 1995 Oct;21 Suppl 2:S178-81;Mol Biol Evol. 2006 Feb;23(2):254-67;Bioinformatics. 2001;17 Suppl 1:S132-9;Adv Exp Med Biol. 2003;529:129-31;Genome Res. 1998 Mar;8(3):175-85;Nucleic Acids Res. 1997 Sep 1;25(17):3389-402;Nature. 2001 Oct 25;413(6858):848-52;J Clin Microbiol. 1994 Mar;32(3):634-41;J Bacteriol. 2001 Apr;183(8):2586-94	MEDLINE	ppublish
33	19820101	2009	Dec			Print-Electronic	Journal Article;Research Support, N.I.H., Extramural;Research Support, Non-U.S. Gov't;Research Support, U.S. Gov't, Non-P.H.S.	Journal of bacteriology	J. Bacteriol.	1098-5530	Draft genome sequences of Yersinia pestis isolates from natural foci of endemic plague in China.	To gain insights into the evolutionary origin, emergence, and pathogenicity of the etiologic agent of plague, we have sequenced the genomes of four Yersinia pestis strains isolated from the zoonotic rodent reservoir in foci of endemic plague in China. These resources enable in-depth studies of Y. pestis sequence variations and detailed whole-genome comparisons of very closely related genomes from the supposed site of the origin and the emergence of global pandemics of plague.	191	24	7628-9	10.1128/JB.01227-09	Eppinger;Guo;Sebastian;Song;Lindler;Yang;Ravel	Mark;Zhaobiao;Yinong;Yajun;Luther E;Ruifu;Jacques	Department of Microbiology and Immunology, Institute for Genome Sciences, University of Maryland, School of Medicine, Baltimore, MD, USA.	eng	J Clin Microbiol. 2000 Apr;38(4):1516-9;Bioinformatics. 2009 Aug 15;25(16):2071-3;J Clin Microbiol. 2001 Sep;39(9):3179-85;Nature. 2001 Oct 4;413(6855):523-7;J Bacteriol. 2002 Feb;184(4):1019-27;J Bacteriol. 2002 Aug;184(16):4601-11;J Bacteriol. 2002 Nov;184(21):6050-5;Nat Rev Microbiol. 2003 Oct;1(1):55-64;Genome Res. 2004 Jul;14(7):1394-403;DNA Res. 2004 Jun 30;11(3):179-97;Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31;Microbes Infect. 2004 Nov;6(13):1226-34;Mol Microbiol. 1992 Sep;6(18):2693-704;Nature. 1999 May 27;399(6734):323-9;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;BMC Bioinformatics. 2005;6:2;J Med Microbiol. 2005 Mar;54(Pt 3):259-68;J Clin Microbiol. 2006 Jun;44(6):2084-92;Arch Microbiol. 2006 Aug;186(2):151-9;PLoS Genet. 2007 Aug;3(8):e142;PLoS One. 2008;3(5):e2166;PLoS Genet. 2008;4(7):e1000128;Infect Immun. 2009 May;77(5):1807-16;Bioinformatics. 2001;17 Suppl 1:S132-9	MEDLINE	ppublish
34	19815893	2009	Oct			Print	Journal Article;Research Support, Non-U.S. Gov't	The American journal of tropical medicine and hygiene	Am. J. Trop. Med. Hyg.	1476-1645	Spatial variation of Yersinia pestis from Yunnan Province of China.	Yunnan Province of China is considered the site of origin for modern plague. We analyzed the genotypes of eight Yersinia pestis strains isolated from three counties in Yunnan Province by pulse field gel electrophoresis (PFGE). PFGE showed that strains isolated from the same site were identical regardless of hosts or year of isolation. However, Y. pestis strains isolated from geographically distinct loci were genetically divergent. Whole genome sequences of two strains from two foci in Yunnan showed that the genetic variation of Y. pestis strains was caused by genome rearrangement. We concluded that Y. pestis strains in each epidemic focus in Yunnan were a clonal population and selected by host environments. The genomic variability of the Y. pestis strains from different foci were caused by genome rearrangement, which may provide a positive selective advantage for Y. pestis to adapt to its host environments.	81	4	714-7	10.4269/ajtmh.2009.09-0174	Zhang;Hai;Song;Xia;Liang;Cai;Liang;Shen;Zhang;Xu;Yu;Yu	Zhikai;Rong;Zhizhong;Lianxu;Yun;Hong;Ying;Xiaona;Enmin;Jianguo;Dongzheng;Xue-Jie	State Key Laboratory for Infectious Disease Prevention and Control, Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.	eng		MEDLINE	ppublish
35	19583835	2009	Jul	07		Electronic	Journal Article;Research Support, Non-U.S. Gov't	BMC genomics	BMC Genomics	1471-2164	Comparative genomics of the emerging human pathogen Photorhabdus asymbiotica with the insect pathogen Photorhabdus luminescens.	The Gram-negative bacterium Photorhabdus asymbiotica (Pa) has been recovered from human infections in both North America and Australia. Recently, Pa has been shown to have a nematode vector that can also infect insects, like its sister species the insect pathogen P. luminescens (Pl). To understand the relationship between pathogenicity to insects and humans in Photorhabdus we have sequenced the complete genome of Pa strain ATCC43949 from North America. This strain (formerly referred to as Xenorhabdus luminescens strain 2) was isolated in 1977 from the blood of an 80 year old female patient with endocarditis, in Maryland, USA. Here we compare the complete genome of Pa ATCC43949 with that of the previously sequenced insect pathogen P. luminescens strain TT01 which was isolated from its entomopathogenic nematode vector collected from soil in Trinidad and Tobago.;We found that the human pathogen Pa had a smaller genome (5,064,808 bp) than that of the insect pathogen Pl (5,688,987 bp) but that each pathogen carries approximately one megabase of DNA that is unique to each strain. The reduced size of the Pa genome is associated with a smaller diversity in insecticidal genes such as those encoding the Toxin complexes (Tc's), Makes caterpillars floppy (Mcf) toxins and the Photorhabdus Virulence Cassettes (PVCs). The Pa genome, however, also shows the addition of a plasmid related to pMT1 from Yersinia pestis and several novel pathogenicity islands including a novel Type Three Secretion System (TTSS) encoding island. Together these data suggest that Pa may show virulence against man via the acquisition of the pMT1-like plasmid and specific effectors, such as SopB, that promote its persistence inside human macrophages. Interestingly the loss of insecticidal genes in Pa is not reflected by a loss of pathogenicity towards insects.;Our results suggest that North American isolates of Pa have acquired virulence against man via the acquisition of a plasmid and specific virulence factors with similarity to those shown to play roles in pathogenicity against humans in other bacteria.	10		302	10.1186/1471-2164-10-302	Wilkinson;Waterfield;Crossman;Corton;Sanchez-Contreras;Vlisidou;Barron;Bignell;Clark;Ormond;Mayho;Bason;Smith;Simmonds;Churcher;Harris;Thompson;Quail;Parkhill;Ffrench-Constant	Paul;Nicholas R;Lisa;Craig;Maria;Isabella;Andrew;Alexandra;Louise;Douglas;Matthew;Nathalie;Frances;Mark;Carol;David;Nicholas R;Michael;Julian;Richard H	School of Biosciences, University of Exeter in Cornwall, Penryn TR10 9EZ, UK. P.A.Wilkinson@exeter.ac.uk	eng	Insect Biochem Mol Biol. 2006 Jun;36(6):517-25;Nat Rev Microbiol. 2004 Oct;2(10):833-41;J Insect Physiol. 2008 Jan;54(1):215-21;Angew Chem Int Ed Engl. 2008;47(10):1942-5;J Bacteriol. 2006 Mar;188(6):2254-61;Chembiochem. 2007 Sep 24;8(14):1721-8;J Bacteriol. 2004 Mar;186(5):1270-9;Curr Issues Mol Biol. 2005 Jul;7(2):197-212;Brief Bioinform. 2003 Jun;4(2):124-32;Trends Microbiol. 2002 Dec;10(12):541-5;Microbiology. 2008 Nov;154(Pt 11):3503-17;FEMS Microbiol Rev. 2003 Jan;26(5):433-56;Annu Rev Biochem. 2007;76:295-329;ISME J. 2008 Aug;2(8):843-52;Mol Microbiol. 1997 Aug;25(3):547-57;FEMS Microbiol Lett. 2002 Sep 10;214(2):241-9;J Bacteriol. 2003 Aug;185(15):4648-56;Infect Immun. 2008 Feb;76(2):612-22;Microbiol Rev. 1996 Mar;60(1):21-43;Infect Immun. 2009 Mar;77(3):1022-30;Environ Microbiol. 2007 Jan;9(1):12-25;Trends Microbiol. 2008 Sep;16(9):436-41;J Bacteriol. 2004 Aug;186(15):5116-28;Trends Microbiol. 2001 Apr;9(4):185-91;FEMS Microbiol Lett. 2003 Dec 12;229(2):265-70;Nature. 2001 Oct 4;413(6855):523-7;J Invertebr Pathol. 2005 Jul;89(3):258-64;Cell Microbiol. 2005 Mar;7(3):363-71;Trends Parasitol. 2007 Nov;23(11):514-7;New Microbiol. 1999 Apr;22(2):117-27;Genome Res. 2003 Jan;13(1):81-90;Appl Environ Microbiol. 2008 Apr;74(8):2275-87;Nucleic Acids Res. 2003 Jan 1;31(1):439-41;FEMS Microbiol Lett. 2004 Apr 15;233(2):223-31;Dev Comp Immunol. 2006;30(12):1099-107;J Bacteriol. 2005 Jan;187(1):77-84;Int J Syst Bacteriol. 1999 Oct;49 Pt 4:1645-56;J Bacteriol. 2001 May;183(10):3117-26;Proteomics. 2006 May;6(9):2705-25;Cell Microbiol. 2008 Nov;10(11):2159-67;J Bacteriol. 2006 Jan;188(2):809-14;Infect Immun. 2004 Nov;72(11):6659-65;Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10742-7;Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19884-9;Nucleic Acids Res. 1999 Dec 1;27(23):4636-41;Nucleic Acids Res. 1998 Jun 15;26(12):2941-7;Microbes Infect. 2004 Feb;6(2):229-37;Cell Microbiol. 2002 Jun;4(6):329-39;Cell Microbiol. 2004 Apr;6(4):345-53;J Mol Biol. 1990 Oct 5;215(3):403-10;FEMS Microbiol Lett. 2005 Apr 1;245(1):47-52;BMC Genomics. 2008;9:40;Toxicon. 2007 Mar 15;49(4):436-51;Curr Biol. 2007 May 15;17(10):898-904;Traffic. 2008 Dec;9(12):2022-31;Appl Environ Microbiol. 2002 Aug;68(8):3780-9;Appl Environ Microbiol. 2008 Dec;74(23):7219-26;Adv Appl Microbiol. 2005;58C:169-183;Bioinformatics. 2000 Oct;16(10):944-5;Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15967-72;Appl Environ Microbiol. 2003 Apr;69(4):1890-7;J Clin Microbiol. 1989 Jul;27(7):1594-600;Annu Rev Microbiol. 1997;51:47-72;Nat Biotechnol. 2003 Oct;21(10):1222-8;Infect Immun. 2005 Feb;73(2):1106-15;J Eukaryot Microbiol. 2008 May-Jun;55(3):235-43;Emerg Infect Dis. 2006 Oct;12(10):1562-4;BMC Microbiol. 2006;6:46;Proteomics. 2007 Dec;7(24):4499-510;Int J Med Microbiol. 2006 Dec;296(8):521-30;J Bacteriol. 2004 Jul;186(13):4376-81;Science. 1998 Jun 26;280(5372):2129-32;Nucleic Acids Res. 2002 Jan 1;30(1):276-80;Cell Microbiol. 2008 Apr;10(4):958-84;Nat Biotechnol. 2003 Nov;21(11):1307-13;Microbes Infect. 2008 Jun;10(7):734-41	MEDLINE	epublish
36	19325880	2009	Mar			Print-Electronic	Journal Article;Research Support, Non-U.S. Gov't	PLoS pathogens	PLoS Pathog.	1553-7374	Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens.	The continued evolution of bacterial pathogens has major implications for both human and animal disease, but the exchange of genetic material between host-restricted pathogens is rarely considered. Streptococcus equi subspecies equi (S. equi) is a host-restricted pathogen of horses that has evolved from the zoonotic pathogen Streptococcus equi subspecies zooepidemicus (S. zooepidemicus). These pathogens share approximately 80% genome sequence identity with the important human pathogen Streptococcus pyogenes. We sequenced and compared the genomes of S. equi 4047 and S. zooepidemicus H70 and screened S. equi and S. zooepidemicus strains from around the world to uncover evidence of the genetic events that have shaped the evolution of the S. equi genome and led to its emergence as a host-restricted pathogen. Our analysis provides evidence of functional loss due to mutation and deletion, coupled with pathogenic specialization through the acquisition of bacteriophage encoding a phospholipase A(2) toxin, and four superantigens, and an integrative conjugative element carrying a novel iron acquisition system with similarity to the high pathogenicity island of Yersinia pestis. We also highlight that S. equi, S. zooepidemicus, and S. pyogenes share a common phage pool that enhances cross-species pathogen evolution. We conclude that the complex interplay of functional loss, pathogenic specialization, and genetic exchange between S. equi, S. zooepidemicus, and S. pyogenes continues to influence the evolution of these important streptococci.	5	3	e1000346	10.1371/journal.ppat.1000346	Holden;Heather;Paillot;Steward;Webb;Ainslie;Jourdan;Bason;Holroyd;Mungall;Quail;Sanders;Simmonds;Willey;Brooks;Aanensen;Spratt;Jolley;Maiden;Kehoe;Chanter;Bentley;Robinson;Maskell;Parkhill;Waller	Matthew T G;Zoe;Romain;Karen F;Katy;Fern;Thibaud;Nathalie C;Nancy E;Karen;Michael A;Mandy;Mark;David;Karen;David M;Brian G;Keith A;Martin C J;Michael;Neil;Stephen D;Carl;Duncan J;Julian;Andrew S	Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.	eng	PLoS One. 2007;2(8):e800;J Bacteriol. 2007 Nov;189(21):7799-807;Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1698-703;Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2128-33;Nat Rev Microbiol. 2008 Mar;6(3):181-6;BMC Microbiol. 2008;8:15;Proc Natl Acad Sci U S A. 1988 Apr;85(8):2444-8;J Mol Biol. 1990 Oct 5;215(3):403-10;Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8317-21;Arch Biochem Biophys. 1994 Dec;315(2):431-7;Res Vet Sci. 1994 Nov;57(3):292-9;Infect Immun. 1996 Dec;64(12):5428-9;Infect Immun. 1997 May;65(5):1659-68;Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16009-14;J Mol Evol. 2008 Jul;67(1):13-22;PLoS One. 2008;3(8):e3026;Microbiology. 2008 Oct;154(Pt 10):3016-24;Infect Immun. 2008 Nov;76(11):5006-15;BMC Genomics. 2009;10:54;Mol Microbiol. 2008 Dec;70(5):1274-92;Infect Immun. 1997 Sep;65(9):3600-5;Infect Immun. 1999 May;67(5):2383-8;J Exp Med. 1959 Mar 1;109(3):257-70;Nat Biotechnol. 2004 Dec;22(12):1554-8;Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1169-74;Science. 2005 Jul 1;309(5731):105;Vet Microbiol. 2005 Aug 10;109(1-2):135-41;Bioinformatics. 2005 Aug 15;21(16):3422-3;J Infect Dis. 2005 Sep 1;192(5):771-82;J Clin Microbiol. 2006 Feb;44(2):480-6;Microbiol Mol Biol Rev. 2006 Mar;70(1):192-221;Proc Natl Acad Sci U S A. 2006 May 2;103(18):7059-64;J Bacteriol. 2006 Sep;188(17):6318-25;Mol Microbiol. 2006 Oct;62(2):320-30;FEMS Microbiol Lett. 2000 Feb 15;183(2):201-7;Lancet. 2000 May 20;355(9217):1776-80;Bioinformatics. 2000 Oct;16(10):944-5;Infect Immun. 2001 May;69(5):3159-63;Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4658-63;Genome Res. 2001 May;11(5):731-53;Science. 2001 Jul 20;293(5529):498-506;Microb Pathog. 2002 Feb;32(2):71-85;Nucleic Acids Res. 2002 Apr 1;30(7):1575-84;Infect Immun. 2002 Jun;70(6):3227-33;Infect Immun. 2002 Jul;70(7):3865-73;Biochem J. 2002 Jul 1;365(Pt 1):317-22;Infect Immun. 2002 Aug;70(8):4204-14;Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10078-83;Mol Microbiol. 2002 Sep;45(6):1499-513;Microbes Infect. 2002 Sep;4(11):1149-56;Plasmid. 2002 Sep;48(2):77-97;Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14434-9;Infect Immun. 2003 Mar;71(3):1361-9;FEMS Microbiol Lett. 2003 May 16;222(1):69-74;Genome Res. 2003 Jun;13(6A):1042-55;Nat Genet. 2003 Sep;35(1):32-40;J Bacteriol. 2003 Nov;185(21):6467-71;Infect Immun. 2003 Dec;71(12):7079-86;Microbiol Mol Biol Rev. 2004 Sep;68(3):560-602, table of contents;Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14246-51;Infect Immun. 1978 Apr;20(1):200-8;J Clin Microbiol. 1985 Apr;21(4):524-6;Proc Natl Acad Sci U S A. 1985 Sep;82(17):5724-7;J Bacteriol. 2007 Feb;189(4):1473-7;Vet Microbiol. 2007 Mar 31;121(1-2):105-15;Science. 2007 Mar 23;315(5819):1709-12;Genetics. 2007 Mar;175(3):1251-66;J Bacteriol. 2007 Apr;189(8):3166-75;Cell Microbiol. 2007 Jun;9(6):1365-75;Microbiology. 2007 Aug;153(Pt 8):2666-78	MEDLINE	ppublish
37	17784789	2007	Aug			Print-Electronic	Comparative Study;Journal Article;Research Support, N.I.H., Extramural	PLoS genetics	PLoS Genet.	1553-7404	The complete genome sequence of Yersinia pseudotuberculosis IP31758, the causative agent of Far East scarlet-like fever.	The first reported Far East scarlet-like fever (FESLF) epidemic swept the Pacific coastal region of Russia in the late 1950s. Symptoms of the severe infection included erythematous skin rash and desquamation, exanthema, hyperhemic tongue, and a toxic shock syndrome. The term FESLF was coined for the infection because it shares clinical presentations with scarlet fever caused by group A streptococci. The causative agent was later identified as Yersinia pseudotuberculosis, although the range of morbidities was vastly different from classical pseudotuberculosis symptoms. To understand the origin and emergence of the peculiar clinical features of FESLF, we have sequenced the genome of the FESLF-causing strain Y. pseudotuberculosis IP31758 and compared it with that of another Y. pseudotuberculosis strain, IP32953, which causes classical gastrointestinal symptoms. The unique gene pool of Y pseudotuberculosis IP31758 accounts for more than 260 strain-specific genes and introduces individual physiological capabilities and virulence determinants, with a significant proportion horizontally acquired that likely originated from Enterobacteriaceae and other soil-dwelling bacteria that persist in the same ecological niche. The mobile genome pool includes two novel plasmids phylogenetically unrelated to all currently reported Yersinia plasmids. An icm/dot type IVB secretion system, shared only with the intracellular persisting pathogens of the order Legionellales, was found on the larger plasmid and could contribute to scarlatinoid fever symptoms in patients due to the introduction of immunomodulatory and immunosuppressive capabilities. We determined the common and unique traits resulting from genome evolution and speciation within the genus Yersinia and drew a more accurate species border between Y. pseudotuberculosis and Y. pestis. In contrast to the lack of genetic diversity observed in the evolutionary young descending Y. pestis lineage, the population genetics of Y. pseudotuberculosis is more heterogenous. Both Y. pseudotuberculosis strains IP31758 and the previously sequenced Y. pseudotuberculosis strain IP32953 have evolved by the acquisition of specific plasmids and by the horizontal acquisition and incorporation of different genetic information into the chromosome, which all together or independently seems to potentially impact the phenotypic adaptation of these two strains.	3	8	e142		Eppinger;Rosovitz;Fricke;Rasko;Kokorina;Fayolle;Lindler;Carniel;Ravel	Mark;M J;Wolfgang Florian;David A;Galina;Corinne;Luther E;Elisabeth;Jacques	J. Craig Venter Institute/The Institute for Genomic Research, Microbial Genomics, Rockville, Maryland, United States of America.	eng	J Clin Microbiol. 1991 Jun;29(6):1271-5;J Bacteriol. 1993 Apr;175(8):2423-35;Chem Pharm Bull (Tokyo). 1993 Feb;41(2):362-8;Microb Pathog. 1993 Jan;14(1):9-21;J Bacteriol. 1993 Aug;175(16):5078-90;J Immunol. 1993 Oct 15;151(8):4183-8;J Immunol. 1993 Oct 15;151(8):4407-13;J Immunol. 1995 May 15;154(10):5228-34;J Bacteriol. 2006 Jan;188(1):255-68;J Bacteriol. 2006 Feb;188(3):977-87;Curr Opin Microbiol. 2006 Feb;9(1):55-61;Microbes Infect. 2004 Nov;6(13):1226-34;Voen Med Zh. 1969 Jan;1:47-51;Pediatriia. 1968 Jan;47(1):33-6;Sov Med. 1969 Dec;32(12):93-7;Pediatriia. 1973 Jan;52(1):6-9;Vopr Okhr Materin Det. 1973 Nov;18(11):46-50;Zh Mikrobiol Epidemiol Immunobiol. 1973 Sep;50(9):125-9;Pediatriia. 1978;(1):23-7;Pediatriia. 1978;(1):27-8;Lab Delo. 1982;(9):559-61;Acta Pathol Microbiol Immunol Scand B. 1983 Aug;91(4):241-4;Science. 1985 Jul 12;229(4709):185-7;Cell. 1987 Aug 28;50(5):769-78;J Med Microbiol. 1987 Nov;24(3):219-26;J Immunol. 1995 Jun 1;154(11):5896-906;Nihon Saikingaku Zasshi. 1995;50(2):501-8;Med Parazitol (Mosk). 1995 Oct-Dec;(4):27-30;J Clin Microbiol. 1995 Dec;33(12):3356-8;Infect Immun. 1996 Jul;64(7):2483-9;J Bacteriol. 1996 Dec;178(23):6743-51;J Bacteriol. 1997 Mar;179(6):2081-5;Microbiol Immunol. 1997;41(4):345-52;Infect Immun. 1997 Aug;65(8):3412-21;FEBS Lett. 1997 Aug 11;413(1):174-6;J Bacteriol. 1998 Aug;180(16):4102-10;Microbiol Mol Biol Rev. 1998 Dec;62(4):1315-52;Nature. 1999 May 27;399(6734):323-9;J Bacteriol. 1999 Jun;181(12):3626-31;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Infect Immun. 2000 May;68(5):2553-9;Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8778-83;Mol Microbiol. 2000 Jul;37(2):316-30;Int J Med Microbiol. 2000 Oct;290(4-5):477-82;Med Parazitol (Mosk). 1999 Oct-Dec;(4):50-3;J Bacteriol. 2001 May;183(10):3134-41;Bioinformatics. 2001;17 Suppl 1:S132-9;J Clin Microbiol. 2001 Oct;39(10):3541-7;J Infect Dis. 2001 Oct 15;184(8):1041-9;Nature. 2001 Oct 4;413(6855):523-7;EMBO J. 2001 Nov 1;20(21):5962-70;J Bacteriol. 2002 Feb;184(3):629-35;Traffic. 2002 Mar;3(3):178-85;Mol Microbiol. 1997 Jul;25(1):161-73;J Bacteriol. 2002 Apr;184(8):2123-30;J Immunol. 2002 Apr 15;168(8):3817-24;J Bacteriol. 2002 Aug;184(16):4489-99;J Bacteriol. 2002 Aug;184(16):4601-11;Annu Rev Microbiol. 2002;56:289-314;Infect Immun. 2002 Nov;70(11):6196-205;Zh Mikrobiol Epidemiol Immunobiol. 2002 Jul-Aug;(4):48-51;Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17020-4;Int J Med Microbiol. 2003 Feb;292(7-8):429-40;Nat Biotechnol. 2003 Nov;21(11):1307-13;Bioinformatics. 2006 May 1;22(9):1072-9;J Bacteriol. 2006 Jun;188(12):4453-63;J Clin Microbiol. 2006 Jun;44(6):2084-92;J Bacteriol. 2006 Jul;188(14):5101-12;Arch Microbiol. 2006 Aug;186(2):151-9;Infect Immun. 2006 Nov;74(11):6487-90;Zh Mikrobiol Epidemiol Immunobiol. 2006 Sep-Oct;(6):20-5;Nucleic Acids Res. 2007 Jan;35(Database issue):D269-70;Science. 2007 Jan 12;315(5809):251-2;Mol Microbiol. 2007 Feb;63(4):1145-57;PLoS Genet. 2006 Dec 15;2(12):e206;Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):841-6;Genome Biol. 2004;5(2):R12;Nat Rev Microbiol. 2003 Oct;1(1):55-64;BMC Microbiol. 2004 Mar 4;4:9;Mol Microbiol. 2004 Jun;52(5):1337-48;Trends Microbiol. 2004 Jun;12(6):296-300;J Bacteriol. 2004 Jun;186(12):3695-702;J Mol Biol. 2004 Jun 25;340(1):49-65;Infect Immun. 2004 Aug;72(8):4784-90;Microbiol Mol Biol Rev. 2004 Sep;68(3):560-602, table of contents;DNA Res. 2004 Jun 30;11(3):179-97;Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31;Infect Immun. 2004 Oct;72(10):5613-21;Infect Immun. 2004 Oct;72(10):5993-6001;Mol Microbiol. 1999 Jul;33(1):167-76;Mol Microbiol. 2004 Nov;54(4):921-34;Microbiology. 2004 Nov;150(Pt 11):3591-9;FEMS Microbiol Lett. 2004 Dec 15;241(2):163-9;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;FEMS Microbiol Rev. 2005 Jan;29(1):65-81;BMC Bioinformatics. 2005;6:2;Infect Immun. 2005 Apr;73(4):2556-8;Curr Top Microbiol Immunol. 2005;289:151-73;J Clin Microbiol. 2005 Sep;43(9):4875-6;Nucleic Acids Res. 2005;33(19):6445-58;Genetika. 1988 Sep;24(9):1562-71;Mol Gen Mikrobiol Virusol. 1989 Jun;(6):20-5;Genetika. 1990 Apr;26(4):621-9	MEDLINE	ppublish
38	17375195	2007	Mar	21		Electronic	Journal Article;Research Support, N.I.H., Extramural;Research Support, U.S. Gov't, Non-P.H.S.	PloS one	PLoS ONE	1932-6203	Multiple antimicrobial resistance in plague: an emerging public health risk.	Antimicrobial resistance in Yersinia pestis is rare, yet constitutes a significant international public health and biodefense threat. In 1995, the first multidrug resistant (MDR) isolate of Y. pestis (strain IP275) was identified, and was shown to contain a self-transmissible plasmid (pIP1202) that conferred resistance to many of the antimicrobials recommended for plague treatment and prophylaxis. Comparative analysis of the DNA sequence of Y. pestis plasmid pIP1202 revealed a near identical IncA/C plasmid backbone that is shared by MDR plasmids isolated from Salmonella enterica serotype Newport SL254 and the fish pathogen Yersinia ruckeri YR71. The high degree of sequence identity and gene synteny between the plasmid backbones suggests recent acquisition of these plasmids from a common ancestor. In addition, the Y. pestis pIP1202-like plasmid backbone was detected in numerous MDR enterobacterial pathogens isolated from retail meat samples collected between 2002 and 2005 in the United States. Plasmid-positive strains were isolated from beef, chicken, turkey and pork, and were found in samples from the following states: California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York and Oregon. Our studies reveal that this common plasmid backbone is broadly disseminated among MDR zoonotic pathogens associated with agriculture. This reservoir of mobile resistance determinants has the potential to disseminate to Y. pestis and other human and zoonotic bacterial pathogens and therefore represents a significant public health concern.	2	3	e309		Welch;Fricke;McDermott;White;Rosso;Rasko;Mammel;Eppinger;Rosovitz;Wagner;Rahalison;Leclerc;Hinshaw;Lindler;Cebula;Carniel;Ravel	Timothy J;W Florian;Patrick F;David G;Marie-Laure;David A;Mark K;Mark;M J;David;Lila;J Eugene;Jeffrey M;Luther E;Thomas A;Elisabeth;Jacques	National Center for Cool and Cold Water Aquaculture, Agricultural Research Service, United States Department of Agriculture (USDA), Kearneysville, West Virginia, United States of America.	eng	Mol Microbiol. 2002 Oct;46(2):349-54;Nature. 2001 Oct 25;413(6858):848-52;J Clin Microbiol. 2003 Dec;41(12):5366-71;Clin Microbiol Rev. 1997 Jan;10(1):35-66;N Engl J Med. 1997 Sep 4;337(10):677-80;J Bacteriol. 1998 Aug;180(16):4102-10;Microbiol Mol Biol Rev. 1999 Sep;63(3):507-22;J Infect Dis. 2006 Jul 15;194(2):222-30;Emerg Infect Dis. 2006 Jul;12(7):1145-8;Microbes Infect. 2006 Jun;8(7):1891-7;Antimicrob Agents Chemother. 2006 Oct;50(10):3233-6;J Med Microbiol. 2006 Nov;55(Pt 11):1461-75;J Bacteriol. 2007 Jan;189(1):52-64;JAMA. 2000 May 3;283(17):2281-90;Emerg Infect Dis. 2001 Jan-Feb;7(1):43-8;J Bacteriol. 2001 Apr;183(8):2586-94;J Infect Dis. 2003 Dec 1;188(11):1707-16	MEDLINE	epublish
39	17311096	2007	Feb	21		Electronic	Journal Article	PloS one	PLoS ONE	1932-6203	A North American Yersinia pestis draft genome sequence: SNPs and phylogenetic analysis.	Yersinia pestis, the causative agent of plague, is responsible for some of the greatest epidemic scourges of mankind. It is widespread in the western United States, although it has only been present there for just over 100 years. As a result, there has been very little time for diversity to accumulate in this region. Much of the diversity that has been detected among North American isolates is at loci that mutate too quickly to accurately reconstruct large-scale phylogenetic patterns. Slowly-evolving but stable markers such as SNPs could be useful for this purpose, but are difficult to identify due to the monomorphic nature of North American isolates.;To identify SNPs that are polymorphic among North American populations of Y. pestis, a gapped genome sequence of Y. pestis strain FV-1 was generated. Sequence comparison of FV-1 with another North American strain, CO92, identified 19 new SNP loci that differ among North American isolates.;The 19 SNP loci identified in this study should facilitate additional studies of the genetic population structure of Y. pestis across North America.	2	2	e220		Touchman;Wagner;Hao;Mastrian;Shah;Vogler;Allender;Clark;Benitez;Youngkin;Girard;Auerbach;Beckstrom-Sternberg;Keim	Jeffrey W;David M;Jicheng;Stephen D;Maulik K;Amy J;Christopher J;Erin A;Debbie S;David J;Jessica M;Raymond K;Stephen M;Paul	The Translational Genomics Research Institute, Phoenix, Ariziona, United States of America. jtouchman@tgen.org	eng	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8408-13;Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31;JAMA. 2000 May 3;283(17):2281-90;Bioinformatics. 1999 May;15(5):426-7;Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13536-41;Genome Res. 1998 Mar;8(3):186-94;Nucleic Acids Res. 2002 Jun 1;30(11):2478-83;Am J Trop Med Hyg. 2002 Feb;66(2):186-96;Genome Res. 2003 Jan;13(1):91-6;Public Health Monogr. 1955;26:1-120;Nucleic Acids Res. 2003 Jul 1;31(13):3518-24;Emerg Infect Dis. 2002 Feb;8(2):225-30;Nature. 2001 Oct 4;413(6855):523-7;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Clin Microbiol Rev. 1997 Jan;10(1):35-66;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;Am J Trop Med Hyg. 1999 Nov;61(5):814-21;Genome Res. 1998 Aug;8(8):848-55;Genome Res. 1998 Mar;8(3):175-85;J Bacteriol. 2006 Jun;188(12):4453-63;Bioinformatics. 2001 Dec;17(12):1244-5	MEDLINE	epublish
40	16740952	2006	Jun			Print	Comparative Study;Journal Article;Research Support, Non-U.S. Gov't;Research Support, U.S. Gov't, Non-P.H.S.	Journal of bacteriology	J. Bacteriol.	0021-9193	Complete genome sequence of Yersinia pestis strains Antiqua and Nepal516: evidence of gene reduction in an emerging pathogen.	Yersinia pestis, the causative agent of bubonic and pneumonic plagues, has undergone detailed study at the molecular level. To further investigate the genomic diversity among this group and to help characterize lineages of the plague organism that have no sequenced members, we present here the genomes of two isolates of the "classical" antiqua biovar, strains Antiqua and Nepal516. The genomes of Antiqua and Nepal516 are 4.7 Mb and 4.5 Mb and encode 4,138 and 3,956 open reading frames, respectively. Though both strains belong to one of the three classical biovars, they represent separate lineages defined by recent phylogenetic studies. We compare all five currently sequenced Y. pestis genomes and the corresponding features in Yersinia pseudotuberculosis. There are strain-specific rearrangements, insertions, deletions, single nucleotide polymorphisms, and a unique distribution of insertion sequences. We found 453 single nucleotide polymorphisms in protein-coding regions, which were used to assess the evolutionary relationships of these Y. pestis strains. Gene reduction analysis revealed that the gene deletion processes are under selective pressure, and many of the inactivations are probably related to the organism's interaction with its host environment. The results presented here clearly demonstrate the differences between the two biovar antiqua lineages and support the notion that grouping Y. pestis strains based strictly on the classical definition of biovars (predicated upon two biochemical assays) does not accurately reflect the phylogenetic relationships within this species. A comparison of four virulent Y. pestis strains with the human-avirulent strain 91001 provides further insight into the genetic basis of virulence to humans.	188	12	4453-63		Chain;Hu;Malfatti;Radnedge;Larimer;Vergez;Worsham;Chu;Andersen	Patrick S G;Ping;Stephanie A;Lyndsay;Frank;Lisa M;Patricia;May C;Gary L	Biosciences Directorate, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.	eng	Emerg Infect Dis. 2004 Sep;10(9):1585-92;J Clin Microbiol. 2001 Sep;39(9):3179-85;Infect Immun. 1984 Mar;43(3):895-900;J Bacteriol. 1989 Jan;171(1):581-4;Microb Pathog. 1992 Mar;12(3):177-86;Nature. 1993 Sep 9;365(6442):126-32;J Clin Microbiol. 1994 Mar;32(3):634-41;Science. 1996 Jul 19;273(5273):367-70;J Clin Microbiol. 1996 Nov;34(11):2829-30;Clin Microbiol Rev. 1997 Jan;10(1):35-66;J Bacteriol. 1997 Jun;179(12):3851-7;Science. 1997 Sep 5;277(5331):1453-62;Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13997-4001;FEBS Lett. 2001 Aug 3;502(3):113-6;Nature. 2001 Oct 4;413(6855):523-7;J Bacteriol. 2002 Feb;184(4):1019-27;Infect Immun. 2002 Mar;70(3):1453-60;Science. 2002 Apr 26;296(5568):733-5;Microbiology. 2002 Jun;148(Pt 6):1687-98;J Bacteriol. 2002 Aug;184(16):4601-11;J Bacteriol. 2002 Nov;184(21):6050-5;J Bacteriol. 2003 May;185(9):2759-73;Genome Res. 2003 Sep;13(9):2018-29;Appl Environ Microbiol. 2003 Nov;69(11):6908-22;Genome Biol. 2004;5(2):R12;J Bacteriol. 2004 Mar;186(6):1638-47;Nat Rev Microbiol. 2003 Oct;1(1):55-64;DNA Res. 2004 Jun 30;11(3):179-97;Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31;Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17837-42;Curr Opin Genet Dev. 2005 Dec;15(6):589-94;Chem Biol. 1998 Oct;5(10):573-86;Mol Microbiol. 1999 Apr;32(2):403-14;J Med Microbiol. 1999 Jun;48(6):551-7;Infect Immun. 1999 Sep;67(9):4851-61;Bull World Health Organ. 1951;4(2):247-63;Am J Phys Anthropol. 2005 Jan;126(1):48-55;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;J Clin Microbiol. 2000 Apr;38(4):1516-9;J Bacteriol. 2000 Jun;182(11):3002-7;Infect Immun. 2000 Aug;68(8):4523-30;J Bacteriol. 2000 Dec;182(24):6913-20;J Bacteriol. 2001 Apr;183(8):2586-94;Appl Environ Microbiol. 2001 Aug;67(8):3759-62;J Biol Chem. 1977 Mar 25;252(6):2154-7	MEDLINE	ppublish
41	15368893	2004	Jun	30		Print	Journal Article	DNA research : an international journal for rapid publication of reports on genes and genomes	DNA Res.	1340-2838	Complete genome sequence of Yersinia pestis strain 91001, an isolate avirulent to humans.	Genomics provides an unprecedented opportunity to probe in minute detail into the genomes of the world's most deadly pathogenic bacteria- Yersinia pestis. Here we report the complete genome sequence of Y. pestis strain 91001, a human-avirulent strain isolated from the rodent Brandt's vole-Microtus brandti. The genome of strain 91001 consists of one chromosome and four plasmids (pPCP1, pCD1, pMT1 and pCRY). The 9609-bp pPCP1 plasmid of strain 91001 is almost identical to the counterparts from reference strains (CO92 and KIM). There are 98 genes in the 70,159-bp range of plasmid pCD1. The 106,642-bp plasmid pMT1 has slightly different architecture compared with the reference ones. pCRY is a novel plasmid discovered in this work. It is 21,742 bp long and harbors a cryptic type IV secretory system. The chromosome of 91001 is 4,595,065 bp in length. Among the 4037 predicted genes, 141 are possible pseudo-genes. Due to the rearrangements mediated by insertion elements, the structure of the 91001 chromosome shows dramatic differences compared with CO92 and KIM. Based on the analysis of plasmids and chromosome architectures, pseudogene distribution, nitrate reduction negative mechanism and gene comparison, we conclude that strain 91001 and other strains isolated from M. brandti might have evolved from ancestral Y. pestis in a different lineage. The large genome fragment deletions in the 91001 chromosome and some pseudogenes may contribute to its unique nonpathogenicity to humans and host-specificity.	11	3	179-97		Song;Tong;Wang;Wang;Guo;Han;Zhang;Pei;Zhou;Qin;Pang;Han;Zhai;Li;Cui;Qi;Jin;Dai;Chen;Li;Ye;Du;Lin;Wang;Yu;Yang;Wang;Huang;Yang	Yajun;Zongzhong;Jin;Li;Zhaobiao;Yanpin;Jianguo;Decui;Dongsheng;Haiou;Xin;Yujun;Junhui;Min;Baizhong;Zhizhen;Lixia;Ruixia;Feng;Shengting;Chen;Zongmin;Wei;Jun;Jun;Huanming;Jian;Peitang;Ruifu	Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, P. R. China.	eng		MEDLINE	ppublish
42	15358858	2004	Sep	21		Print-Electronic	Journal Article;Research Support, Non-U.S. Gov't;Research Support, U.S. Gov't, Non-P.H.S.	Proceedings of the National Academy of Sciences of the United States of America	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis.	Yersinia pestis, the causative agent of plague, is a highly uniform clone that diverged recently from the enteric pathogen Yersinia pseudotuberculosis. Despite their close genetic relationship, they differ radically in their pathogenicity and transmission. Here, we report the complete genomic sequence of Y. pseudotuberculosis IP32953 and its use for detailed genome comparisons with available Y. pestis sequences. Analyses of identified differences across a panel of Yersinia isolates from around the world reveal 32 Y. pestis chromosomal genes that, together with the two Y. pestis-specific plasmids, to our knowledge, represent the only new genetic material in Y. pestis acquired since the the divergence from Y. pseudotuberculosis. In contrast, 149 other pseudogenes (doubling the previous estimate) and 317 genes absent from Y. pestis were detected, indicating that as many as 13% of Y. pseudotuberculosis genes no longer function in Y. pestis. Extensive insertion sequence-mediated genome rearrangements and reductive evolution through massive gene loss, resulting in elimination and modification of preexisting gene expression pathways, appear to be more important than acquisition of genes in the evolution of Y. pestis. These results provide a sobering example of how a highly virulent epidemic clone can suddenly emerge from a less virulent, closely related progenitor.	101	38	13826-31		Chain;Carniel;Larimer;Lamerdin;Stoutland;Regala;Georgescu;Vergez;Land;Motin;Brubaker;Fowler;Hinnebusch;Marceau;Medigue;Simonet;Chenal-Francisque;Souza;Dacheux;Elliott;Derbise;Hauser;Garcia	P S G;E;F W;J;P O;W M;A M;L M;M L;V L;R R;J;J;M;C;M;V;B;D;J M;A;L J;E	Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.	eng	J Bacteriol. 1964 Sep;88:553-8;J Bacteriol. 1978 Nov;136(2):757-64;Nat Rev Mol Cell Biol. 2002 Oct;3(10):742-52;Microb Pathog. 1998 Dec;25(6):343-8;Mol Gen Mikrobiol Virusol. 1986 Jun;(6):3-11;Adv Exp Med Biol. 2003;529:55-62;Mol Microbiol. 1998 Dec;30(5):965-78;J Bacteriol. 2003 May;185(9):2759-73;Infect Immun. 2003 Jul;71(7):3673-81;Plasmid. 2004 Jan;51(1):1-11;Microbiology. 2003 Oct;149(Pt 10):2829-45;Nature. 2001 Oct 4;413(6855):523-7;J Bacteriol. 1962 Jul;84:53-9;Nature. 2001 Jul 5;412(6842):83-6;J Bacteriol. 1981 Jan;145(1):452-8;Science. 2002 Apr 26;296(5568):733-5;Infect Immun. 1998 Oct;66(10):4611-23;J Bacteriol. 2002 Aug;184(16):4601-11;Appl Environ Microbiol. 2003 Aug;69(8):4474-81;Infect Immun. 1998 Dec;66(12):5755-62;Nat Rev Microbiol. 2003 Oct;1(1):55-64;Nature. 2001 Feb 22;409(6823):1007-11;J Bacteriol. 1962 Nov;84(5):1122-3;FEMS Microbiol Lett. 1990 Jan 15;55(1-2):45-8;J Bacteriol. 2002 Feb;184(4):1019-27;Infect Immun. 1970 May;1(5):446-54;J Bacteriol. 2002 Nov;184(21):6050-5;J Bacteriol. 2003 Jan;185(2):534-43;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Infect Immun. 1999 Mar;67(3):1359-67;Genome Res. 2003 Sep;13(9):2018-29;J Bacteriol. 1998 Oct;180(19):5192-202;J Bacteriol. 2002 Jun;184(12):3214-23;Mol Microbiol. 2004 Jun;52(5):1337-48;Mol Microbiol. 1997 Jun;24(6):1157-68;Vet Microbiol. 2002 Dec 20;90(1-4):341-8;Eukaryot Cell. 2002 Oct;1(5):657-62;Clin Infect Dis. 1995 Oct;21 Suppl 2:S178-81;Microbiology. 2002 Jun;148(Pt 6):1687-98;Nature. 2001 Oct 25;413(6858):848-52;Annu Rev Microbiol. 2000;54:735-74;Infect Immun. 2001 Jan;69(1):170-6;Science. 1965 Jul 23;149(3682):422-4	MEDLINE	ppublish
43	15262951	2004	Aug			Print	Comparative Study;Journal Article;Research Support, Non-U.S. Gov't	Journal of bacteriology	J. Bacteriol.	0021-9193	Genetics of metabolic variations between Yersinia pestis biovars and the proposal of a new biovar, microtus.	Yersinia pestis has been historically divided into three biovars: antiqua, mediaevalis, and orientalis. On the basis of this study, strains from Microtus-related plague foci are proposed to constitute a new biovar, microtus. Based on the ability to ferment glycerol and arabinose and to reduce nitrate, Y. pestis strains can be assigned to one of four biovars: antiqua (glycerol positive, arabinose positive, and nitrate positive), mediaevalis (glycerol positive, arabinose positive, and nitrate negative), orientalis (glycerol negative, arabinose positive, and nitrate positive), and microtus (glycerol positive, arabinose negative, and nitrate negative). A 93-bp in-frame deletion in glpD gene results in the glycerol-negative characteristic of biovar orientalis strains. Two kinds of point mutations in the napA gene may cause the nitrate reduction-negative characteristic in biovars mediaevalis and microtus, respectively. A 122-bp frameshift deletion in the araC gene may lead to the arabinose-negative phenotype of biovar microtus strains. Biovar microtus strains have a unique genomic profile of gene loss and pseudogene distribution, which most likely accounts for the human attenuation of this new biovar. Focused, hypothesis-based investigations on these specific genes will help delineate the determinants that enable this deadly pathogen to be virulent to humans and give insight into the evolution of Y. pestis and plague pathogenesis. Moreover, there may be the implications for development of biovar microtus strains as a potential vaccine.	186	15	5147-52		Zhou;Tong;Song;Han;Pei;Pang;Zhai;Li;Cui;Qi;Jin;Dai;Du;Wang;Guo;Wang;Huang;Yang	Dongsheng;Zongzhong;Yajun;Yanping;Decui;Xin;Junhui;Min;Baizhong;Zhizhen;Lixia;Ruixia;Zongmin;Jin;Zhaobiao;Jian;Peitang;Ruifu	Laboratory of Analytical Microbiology, National Center for Biomedical Analysis, Army Center for Microbial Detection and Research, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China. yangrf@nic.bmi.ac.cn	eng	Microbiol Immunol. 2004;48(4):263-9;Cold Spring Harb Symp Quant Biol. 1966;31:345-7;Clin Microbiol Rev. 1997 Jan;10(1):35-66;Structure. 1999 Jan 15;7(1):65-79;Cell Mol Life Sci. 2001 Feb;58(2):165-78;Nature. 2001 Oct 4;413(6855):523-7;J Bacteriol. 2002 Feb;184(4):1019-27;J Bacteriol. 2002 Aug;184(16):4601-11;J Bacteriol. 2002 Nov;184(21):6050-5;Nat Rev Microbiol. 2003 Oct;1(1):55-64	MEDLINE	ppublish
44	12923098	2003	Sep			Print	Comparative Study;Journal Article;Research Support, U.S. Gov't, Non-P.H.S.;Research Support, U.S. Gov't, P.H.S.	Journal of bacteriology	J. Bacteriol.	0021-9193	The genome sequence of Yersinia pestis bacteriophage phiA1122 reveals an intimate history with the coliphage T3 and T7 genomes.	The genome sequence of bacteriophage phiA1122 has been determined. phiA1122 grows on almost all isolates of Yersinia pestis and is used by the Centers for Disease Control and Prevention as a diagnostic agent for the causative agent of plague. phiA1122 is very closely related to coliphage T7; the two genomes are colinear, and the genome-wide level of nucleotide identity is about 89%. However, a quarter of the phiA1122 genome, one that includes about half of the morphogenetic and maturation functions, is significantly more closely related to coliphage T3 than to T7. It is proposed that the yersiniophage phiA1122 recombined with a close relative of the Y. enterocolitica phage phiYeO3-12 to yield progeny phages, one of which became the classic T3 coliphage of Demerec and Fano (M. Demerec and U. Fano, Genetics 30:119-136, 1945).	185	17	5248-62		Garcia;Elliott;Ramanculov;Chain;Chu;Molineux	Emilio;Jeffrey M;Erlan;Patrick S G;May C;Ian J	Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, Livermore, CA, USA.	eng	Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4034-8;Zh Mikrobiol Epidemiol Immunobiol. 1990 Nov;(11):9-12;Virology. 1989 Aug;171(2):588-98;J Virol. 1988 Nov;62(11):4369-71;J Mol Biol. 1981 Dec 15;153(3):493-502;Proc Natl Acad Sci U S A. 1977 Mar;74(3):822-6;Genome Res. 1998 Mar;8(3):195-202;J Biol Chem. 1981 Mar 10;256(5):2579-85;J Mol Biol. 1997 May 30;269(1):10-27;Infect Immun. 1971 Jul;4(1):85-7;Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1761-5;Nature. 2001 Oct 4;413(6855):523-7;Biochem Biophys Res Commun. 1968 May 23;31(4):609-15;Annu Rev Microbiol. 2001;55:437-51;J Virol. 1981 Jan;37(1):343-51;Genome Res. 1998 Mar;8(3):186-94;J Mol Biol. 1983 Jun 5;166(4):477-535;Ann Inst Pasteur (Paris). 1947 Apr;73(4):348-63;Proc Natl Acad Sci U S A. 1980 Jul;77(7):3917-21;J Bacteriol. 2002 Aug;184(16):4601-11;Vestn Ross Akad Med Nauk. 1999;(12):24-9;Genetics. 1945 Mar;30(2):119-36;Mol Gen Genet. 1982;188(2):211-8;J Mol Biol. 1979 Dec 25;135(4):917-37;J Bacteriol. 1993 Jul;175(14):4354-63;Ann Inst Pasteur (Paris). 1947 Oct;73(10):937-56;J Mol Biol. 1973 Sep 15;79(2):227-36;J Bacteriol. 2001 Mar;183(6):1928-37;JAMA. 2000 May 3;283(17):2281-90;Zh Mikrobiol Epidemiol Immunobiol. 1994 Nov-Dec;(6):9-10;Virology. 1979 May;95(1):70-84;J Mol Biol. 1988 Mar 20;200(2):351-65;Am J Clin Pathol. 1953 Jun;23(6):619-20;Biochem Biophys Res Commun. 1970;39(6):1017-20;J Mol Biol. 1989 Jun 5;207(3):563-74;J Mol Biol. 1990 Oct 5;215(3):403-10;J Mol Biol. 1998 Jul 10;280(2):201-13;J Virol. 1973 Feb;11(2):306-13;J Mol Biol. 1973 Jun 25;77(2):189-96;J Mol Biol. 1975 Dec 15;99(3):487-99;J Bacteriol. 1986 Jul;167(1):251-6;J Infect Dis. 1951 May-Jun;88(3):254-5;Proc Natl Acad Sci U S A. 2000 May 9;97(10):5375-80;J Mol Biol. 1990 Dec 20;216(4):939-48;J Bacteriol. 1947 Jun;53(6):705-14;J Virol. 1969 Dec;4(6):896-900;Nucleic Acids Res. 2001 Jul 15;29(14):3059-68;J Mol Biol. 1995 Jul 7;250(2):156-68;Biochemistry. 2000 Aug 29;39(34):10419-30;Proc Natl Acad Sci U S A. 1976 Mar;73(3):780-4;J Mol Biol. 1999 Jun 18;289(4):815-26;J Bacteriol. 1991 Feb;173(4):1536-43;J Mol Biol. 1981 Mar 25;147(1):41-53;Lab Delo. 1969;3:179;Genome Res. 1998 Mar;8(3):175-85;J Mol Biol. 2002 Jun 21;319(5):1115-32;J Mol Biol. 1992 Nov 20;228(2):506-15;J Bacteriol. 1971 Aug;107(2):420-32;Cell. 1981 Dec;27(3 Pt 2):533-42;J Virol. 1968 Apr;2(4):335-45;Mol Gen Genet. 1999 Dec;262(4-5):659-67	MEDLINE	ppublish
45	12834539	2003	Jun	30		Electronic	Journal Article;Research Support, Non-U.S. Gov't	BMC microbiology	BMC Microbiol.	1471-2180	Annotation and evolutionary relationships of a small regulatory RNA gene micF and its target ompF in Yersinia species.	micF RNA, a small regulatory RNA found in bacteria, post-transcriptionally regulates expression of outer membrane protein F (OmpF) by interaction with the ompF mRNA 5'UTR. Phylogenetic data can be useful for RNA/RNA duplex structure analyses and aid in elucidation of mechanism of regulation. However micF and associated genes, ompF and ompC are difficult to annotate because of either similarities or divergences in nucleotide sequence. We report by using sequences that represent "gene signatures" as probes, e.g., mRNA 5'UTR sequences, closely related genes can be accurately located in genomic sequences.;Alignment and search methods using NCBI BLAST programs have been used to identify micF, ompF and ompC in Yersinia pestis and Yersinia enterocolitica. By alignment with DNA sequences from other bacterial species, 5' start sites of genes and upstream transcriptional regulatory sites in promoter regions were predicted. Annotated genes from Yersinia species provide phylogenetic information on the micF regulatory system. High sequence conservation in binding sites of transcriptional regulatory factors are found in the promoter region upstream of micF and conservation in blocks of sequences as well as marked sequence variation is seen in segments of the micF RNA gene. Unexpected large differences in rates of evolution were found between the interacting RNA transcripts, micF RNA and the 5' UTR of the ompF mRNA. micF RNA/ompF mRNA 5' UTR duplex structures were modeled by the mfold program. Functional domains such as RNA/RNA interacting sites appear to display a minimum of evolutionary drift in sequence with the exception of a significant change in Y. enterocolitica micF RNA.;Newly annotated Yersinia micF and ompF genes and the resultant RNA/RNA duplex structures add strong phylogenetic support for a generalized duplex model. The alignment and search approach using 5' UTR signatures may be a model to help define other genes and their start sites when annotated genes are available in well-defined reference organisms.	3		13		Delihas	Nicholas	Department of Molecular Genetics and Microbiology, School of Medicine, SUNY Stony Brook, NY 11794-5222, USA. nicholas.delihas@stonybrook.edu	eng	Nucleic Acids Res. 2001 Nov 15;29(22):4724-35;J Mol Biol. 2001 Oct 12;313(1):1-12;Nucleic Acids Res. 2002 Jan 1;30(1):276-80;Biochem Biophys Res Commun. 2002 Mar 8;291(4):979-86;RNA. 2002 Apr;8(4):534-41;Mol Microbiol. 2002 Jan;43(2):355-70;Mol Microbiol. 2002 Jun;44(5):1235-50;Int J Syst Evol Microbiol. 2002 Jul;52(Pt 4):1305-8;Cell. 2002 Sep 6;110(5):551-61;Genome Res. 2002 Oct;12(10):1619-23;J Bacteriol. 2002 Nov;184(21):5880-93;Mol Cell. 2002 Sep;10(3):437-9;Annu Rev Cell Biol. 1988;4:21-42;J Biol Chem. 1989 Jun 15;264(17):10104-9;Antimicrob Agents Chemother. 1989 Mar;33(3):283-90;J Biol Chem. 1989 Oct 25;264(30):17961-70;Appl Environ Microbiol. 1990 Jan;56(1):181-6;J Bacteriol. 1991 Aug;173(15):4578-86;Mol Microbiol. 1994 May;12(4):639-46;Microbiol Rev. 1994 Sep;58(3):466-90;J Bacteriol. 1995 Jan;177(1):103-13;Biochemistry. 1995 Mar 21;34(11):3621-31;J Bacteriol. 1995 Oct;177(20):5872-7;J Bacteriol. 1996 Jun;178(12):3650-3;Mol Microbiol. 1996 Jun;20(5):911-7;Mol Microbiol. 1995 Nov;18(4):779-89;Microbiol Rev. 1996 Mar;60(1):21-43;Curr Opin Struct Biol. 1997 Feb;7(1):86-93;Nat Biotechnol. 1997 Aug;15(8):751-3;Microbiol Mol Biol Rev. 1997 Dec;61(4):393-410;Nucleic Acids Symp Ser. 1997;(36):33-5;Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10413-8;Bioinformatics. 1998;14(8):691-9;Nucleic Acids Res. 1999 Jan 1;27(1):12-7;J Mol Biol. 1999 May 21;288(5):911-40;Bioinformatics. 1999 Jun;15(6):471-9;Mol Microbiol. 1999 Nov;34(3):431-41;Mol Microbiol. 2000 Feb;35(3):623-34;Nat Struct Biol. 2000 May;7(5):424-30;Bioinformatics. 2000 Dec;16(12):1145-50;Nucleic Acids Res. 2001 Sep 1;29(17):3583-94;Nature. 2001 Oct 4;413(6855):523-7;Nucleic Acids Res. 2002 Jan 1;30(1):239-41	MEDLINE	epublish
46	12142430	2002	Aug			Print	Comparative Study;Journal Article;Research Support, U.S. Gov't, P.H.S.	Journal of bacteriology	J. Bacteriol.	0021-9193	Genome sequence of Yersinia pestis KIM.	We present the complete genome sequence of Yersinia pestis KIM, the etiologic agent of bubonic and pneumonic plague. The strain KIM, biovar Mediaevalis, is associated with the second pandemic, including the Black Death. The 4.6-Mb genome encodes 4,198 open reading frames (ORFs). The origin, terminus, and most genes encoding DNA replication proteins are similar to those of Escherichia coli K-12. The KIM genome sequence was compared with that of Y. pestis CO92, biovar Orientalis, revealing homologous sequences but a remarkable amount of genome rearrangement for strains so closely related. The differences appear to result from multiple inversions of genome segments at insertion sequences, in a manner consistent with present knowledge of replication and recombination. There are few differences attributable to horizontal transfer. The KIM and E. coli K-12 genome proteins were also compared, exposing surprising amounts of locally colinear "backbone," or synteny, that is not discernible at the nucleotide level. Nearly 54% of KIM ORFs are significantly similar to K-12 proteins, with conserved housekeeping functions. However, a number of E. coli pathways and transport systems and at least one global regulator were not found, reflecting differences in lifestyle between them. In KIM-specific islands, new genes encode candidate pathogenicity proteins, including iron transport systems, putative adhesins, toxins, and fimbriae.	184	16	4601-11		Deng;Burland;Plunkett;Boutin;Mayhew;Liss;Perna;Rose;Mau;Zhou;Schwartz;Fetherston;Lindler;Brubaker;Plano;Straley;McDonough;Nilles;Matson;Blattner;Perry	Wen;Valerie;Guy;Adam;George F;Paul;Nicole T;Debra J;Bob;Shiguo;David C;Jaqueline D;Luther E;Robert R;Gregory V;Susan C;Kathleen A;Matthew L;Jyl S;Frederick R;Robert D	Laboratory of Genetics, University of Wisconsin, Madison, Wisconsin 53706, USA.	eng	Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Clin Microbiol Rev. 1997 Jan;10(1):35-66;Infect Immun. 2000 Mar;68(3):1400-7;FEBS Lett. 2000 Apr 21;472(1):22-6;Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9419-24;J Bacteriol. 2000 Nov;182(21):6169-76;Nature. 2001 Jan 25;409(6819):529-33;Genome Biol. 2000;1(6):RESEARCH0011;EMBO Rep. 2001 Mar;2(3):244-8;Biochimie. 2001 Feb;83(2):161-70;Genome Res. 2001 Sep;11(9):1584-93;Infect Immun. 2001 Oct;69(10):6201-8;J Bacteriol. 2001 Oct;183(20):5927-36;Science. 1997 Sep 5;277(5331):1453-62;J Clin Microbiol. 1997 Nov;35(11):2826-33;Infect Immun. 1997 Dec;65(12):5371-5;Nucleic Acids Res. 1998 Jan 15;26(2):544-8;Infect Immun. 1998 Jul;66(7):3208-17;J Bacteriol. 1998 Oct;180(19):5192-202;Infect Immun. 1998 Oct;66(10):4611-23;Chem Biol. 1998 Oct;5(10):573-86;Infect Immun. 1998 Dec;66(12):5731-42;Gene. 1998 Nov 26;223(1-2):47-54;J Bacteriol. 1999 Mar;181(6):1767-78;J Bacteriol. 1999 Aug;181(16):4896-904;Infect Immun. 1999 Sep;67(9):4851-61;Science. 1999 Sep 3;285(5433):1558-62;Nature. 2001 Oct 4;413(6855):523-7;J Mol Evol. 1987;26(1-2):74-86;Science. 1988 Sep 9;241(4871):1314-8;J Bacteriol. 1990 Oct;172(10):5929-37;J Mol Biol. 1990 Oct 5;215(3):403-10;Genomics. 1993 Jun;16(3):551-61;Nucleic Acids Res. 1993 Jul 25;21(15):3385-90;J Clin Microbiol. 1994 Mar;32(3):634-41;Mol Microbiol. 1994 Jun;12(6):865-71;Mol Microbiol. 1994 Aug;13(4):697-708;Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6244-8;Trends Microbiol. 1995 Aug;3(8):310-7;Trends Genet. 1996 Feb;12(2):76-8;J Bacteriol. 1996 Nov;178(21):6145-50;Biochimie. 1996;78(5):302-10;Microbiol Mol Biol Rev. 1999 Dec;63(4):751-813, table of contents	MEDLINE	ppublish
47	11677608	2001	Oct	25		Print	Journal Article;Research Support, Non-U.S. Gov't	Nature	Nature	0028-0836	Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18.	Salmonella enterica serovar Typhi (S. typhi) is the aetiological agent of typhoid fever, a serious invasive bacterial disease of humans with an annual global burden of approximately 16 million cases, leading to 600,000 fatalities. Many S. enterica serovars actively invade the mucosal surface of the intestine but are normally contained in healthy individuals by the local immune defence mechanisms. However, S. typhi has evolved the ability to spread to the deeper tissues of humans, including liver, spleen and bone marrow. Here we have sequenced the 4,809,037-base pair (bp) genome of a S. typhi (CT18) that is resistant to multiple drugs, revealing the presence of hundreds of insertions and deletions compared with the Escherichia coli genome, ranging in size from single genes to large islands. Notably, the genome sequence identifies over two hundred pseudogenes, several corresponding to genes that are known to contribute to virulence in Salmonella typhimurium. This genetic degradation may contribute to the human-restricted host range for S. typhi. CT18 harbours a 218,150-bp multiple-drug-resistance incH1 plasmid (pHCM1), and a 106,516-bp cryptic plasmid (pHCM2), which shows recent common ancestry with a virulence plasmid of Yersinia pestis.	413	6858	848-52		Parkhill;Dougan;James;Thomson;Pickard;Wain;Churcher;Mungall;Bentley;Holden;Sebaihia;Baker;Basham;Brooks;Chillingworth;Connerton;Cronin;Davis;Davies;Dowd;White;Farrar;Feltwell;Hamlin;Haque;Hien;Holroyd;Jagels;Krogh;Larsen;Leather;Moule;O'Gaora;Parry;Quail;Rutherford;Simmonds;Skelton;Stevens;Whitehead;Barrell	J;G;K D;N R;D;J;C;K L;S D;M T;M;S;D;K;T;P;A;P;R M;L;N;J;T;N;A;T T;S;K;A;T S;S;S;P;C;M;K;M;J;K;S;B G	The Sanger Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. parkhill@sanger.ac.uk	eng		MEDLINE	ppublish
48	11586360	2001	Oct	04		Print	Journal Article	Nature	Nature	0028-0836	Genome sequence of Yersinia pestis, the causative agent of plague.	The Gram-negative bacterium Yersinia pestis is the causative agent of the systemic invasive infectious disease classically referred to as plague, and has been responsible for three human pandemics: the Justinian plague (sixth to eighth centuries), the Black Death (fourteenth to nineteenth centuries) and modern plague (nineteenth century to the present day). The recent identification of strains resistant to multiple drugs and the potential use of Y. pestis as an agent of biological warfare mean that plague still poses a threat to human health. Here we report the complete genome sequence of Y. pestis strain CO92, consisting of a 4.65-megabase (Mb) chromosome and three plasmids of 96.2 kilobases (kb), 70.3 kb and 9.6 kb. The genome is unusually rich in insertion sequences and displays anomalies in GC base-composition bias, indicating frequent intragenomic recombination. Many genes seem to have been acquired from other bacteria and viruses (including adhesins, secretion systems and insecticidal toxins). The genome contains around 150 pseudogenes, many of which are remnants of a redundant enteropathogenic lifestyle. The evidence of ongoing genome fluidity, expansion and decay suggests Y. pestis is a pathogen that has undergone large-scale genetic flux and provides a unique insight into the ways in which new and highly virulent pathogens evolve.	413	6855	523-7		Parkhill;Wren;Thomson;Titball;Holden;Prentice;Sebaihia;James;Churcher;Mungall;Baker;Basham;Bentley;Brooks;Cerdeño-Tárraga;Chillingworth;Cronin;Davies;Davis;Dougan;Feltwell;Hamlin;Holroyd;Jagels;Karlyshev;Leather;Moule;Oyston;Quail;Rutherford;Simmonds;Skelton;Stevens;Whitehead;Barrell	J;B W;N R;R W;M T;M B;M;K D;C;K L;S;D;S D;K;A M;T;A;R M;P;G;T;N;S;K;A V;S;S;P C;M;K;M;J;K;S;B G	The Sanger Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK. parkhill@sanger.ac.uk	eng		MEDLINE	ppublish
49	11274119	2001	Apr			Print	Journal Article;Research Support, Non-U.S. Gov't	Journal of bacteriology	J. Bacteriol.	0021-9193	Yersinia pestis pFra shows biovar-specific differences and recent common ancestry with a Salmonella enterica serovar Typhi plasmid.	Population genetic studies suggest that Yersinia pestis, the cause of plague, is a clonal pathogen that has recently emerged from Yersinia pseudotuberculosis. Plasmid acquisition is likely to have been a key element in this evolutionary leap from an enteric to a flea-transmitted systemic pathogen. However, the origin of Y. pestis-specific plasmids remains obscure. We demonstrate specific plasmid rearrangements in different Y. pestis strains which distinguish Y. pestis bv. Orientalis strains from other biovars. We also present evidence for plasmid-associated DNA exchange between Y. pestis and the exclusively human pathogen Salmonella enterica serovar Typhi.	183	8	2586-94		Prentice;James;Parkhill;Baker;Stevens;Simmonds;Mungall;Churcher;Oyston;Titball;Wren;Wain;Pickard;Hien;Farrar;Dougan	M B;K D;J;S G;K;M N;K L;C;P C;R W;B W;J;D;T T;J J;G	Department of Medical Microbiology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London, United Kingdom. m.b.prentice@mds.qmw.ac.uk	eng	J Bacteriol. 1994 Aug;176(15):4543-8;Res Microbiol. 1999 Nov-Dec;150(9-10):579-87;Mol Microbiol. 1991 Mar;5(3):585-93;Nature. 1988 Aug 11;334(6182):522-4;Genetika. 1998 Feb;34(2):198-205;Gene. 2000 Feb 8;243(1-2):47-57;Nucleic Acids Res. 1998 Jan 15;26(2):544-8;J Mol Biol. 1989 Dec 5;210(3):485-95;Mol Microbiol. 1998 Mar;27(5):1021-9;J Bacteriol. 1996 Sep;178(17):5323-6;J Gen Microbiol. 1993 Jun;139 Pt 6:1125-32;Mol Microbiol. 1998 Dec;30(5):965-78;J Bacteriol. 2000 Apr;182(7):2043-7;Int J Syst Bacteriol. 1997 Oct;47(4):1253-4;Science. 1992 Nov 6;258(5084):1004-7;Appl Environ Microbiol. 2000 Oct;66(10):4414-20;Wkly Epidemiol Rec. 1999 Oct 15;74(41):340-4;Microb Comp Genomics. 1997;2(4):287-98;N Engl J Med. 1997 Sep 4;337(10):677-80;Science. 1996 Jul 19;273(5273):367-70;Infect Immun. 1997 Jan;65(1):327-30;Infect Immun. 1998 Dec;66(12):5731-42;Nature. 2000 Feb 10;403(6770):665-8;Plasmid. 1999 Sep;42(2):73-91;Infect Immun. 1998 Oct;66(10):4611-23;Nucleic Acids Res. 1997 Mar 1;25(5):955-64;Nucleic Acids Res. 1998 Sep 15;26(18):4196-204;Arch Intern Med. 1992 Jun;152(6):1253-6;Infect Immun. 1995 Feb;63(2):563-8;Mol Biol Evol. 1995 Mar;12(2):198-207;Infect Immun. 1982 Jun;36(3):1160-7;Nucleic Acids Res. 2000 May 15;28(10):2177-86;Microbiology. 1996 Jul;142 ( Pt 7):1847-53;Trends Microbiol. 1998 Apr;6(4):131-3;FEMS Microbiol Lett. 1990 Jan 15;55(1-2):45-8;Mol Microbiol. 1997 Mar;23(6):1089-97;Infect Immun. 1970 May;1(5):446-54;Infect Immun. 1999 Oct;67(10):5455-62;Curr Opin Microbiol. 1999 Oct;2(5):483-8;Nucleic Acids Res. 1998 Jun 15;26(12):2941-7;Infect Immun. 1999 Sep;67(9):4851-61;Int J Syst Bacteriol. 1999 Oct;49 Pt 4:1433-8;Genetics. 1996 Jul;143(3):1091-100;J Mol Biol. 1990 Oct 5;215(3):403-10;Bull World Health Organ. 1951;4(2):247-63;J Bacteriol. 1999 Sep;181(18):5572-80;Microb Pathog. 1991 Aug;11(2):123-8;Mol Microbiol. 1997 Dec;26(5):1005-11;Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8;Infect Immun. 1991 May;59(5):1860-3;Infect Immun. 1989 May;57(5):1517-23;J Mol Med (Berl). 1997 Sep;75(9):645-52;Microbiology. 2000 Sep;146 ( Pt 9):2267-75;Emerg Infect Dis. 1998 Jan-Mar;4(1):101-4;FEBS Lett. 2000 Apr 21;472(1):22-6;Plasmid. 2000 Mar;43(2):144-8;Genes Dev. 1999 Apr 1;13(7):890-900;J Bacteriol. 1998 Oct;180(19):5192-202;Microbiology. 1996 Dec;142 ( Pt 12):3415-24;Bioinformatics. 2000 Oct;16(10):944-5;Mol Microbiol. 2000 Jan;35(1):1-5;Int J Med Microbiol. 2000 Oct;290(4-5):483-7;Infect Immun. 2000 Jun;68(6):3419-25;Clin Microbiol Rev. 1991 Jul;4(3):309-24;Clin Microbiol Rev. 1997 Jan;10(1):35-66;Am J Trop Med Hyg. 1994 Jul;51(1):109-14;Infect Immun. 2000 Aug;68(8):4523-30;Infect Immun. 1990 Jul;58(7):2262-75;Nucleic Acids Res. 2000 Jan 1;28(1):263-6;Clin Infect Dis. 1995 Oct;21 Suppl 2:S178-81;Infect Immun. 1992 Dec;60(12):5242-52;Infect Immun. 1996 Jan;64(1):375-9;J Clin Microbiol. 1994 Mar;32(3):634-41;J Bacteriol. 2000 Jul;182(14):3924-8;Mol Microbiol. 2000 Jun;36(5):1006-14	MEDLINE	ppublish
50	9826348	1998	Dec			Print	Comparative Study;Journal Article;Research Support, U.S. Gov't, Non-P.H.S.;Research Support, U.S. Gov't, P.H.S.	Infection and immunity	Infect. Immun.	0019-9567	Complete DNA sequence and detailed analysis of the Yersinia pestis KIM5 plasmid encoding murine toxin and capsular antigen.	Yersinia pestis, the causative agent of plague, harbors at least three plasmids necessary for full virulence of the organism, two of which are species specific. One of the Y. pestis-specific plasmids, pMT1, is thought to promote deep tissue invasion, resulting in more acute onset of symptoms and death. We determined the entire nucleotide sequence of Y. pestis KIM5 pMT1 and identified potential open reading frames (ORFs) encoded by the 100,990-bp molecule. Based on codon usage for known yersinial genes, homology with known proteins in the databases, and potential ribosome binding sites, we determined that 115 of the potential ORFs which we considered could encode polypeptides in Y. pestis. Five of these ORFs were genes previously identified as being necessary for production of the classic virulence factors, murine toxin (MT), and the fraction 1 (F1) capsule antigen. The regions of pMT1 encoding MT and F1 were surrounded by remnants of multiple transposition events and bacteriophage, respectively, suggesting horizontal gene transfer of these virulence factors. We identified seven new potential virulence factors that might interact with the mammalian host or flea vector. Forty-three of the remaining 115 putative ORFs did not display any significant homology with proteins in the current databases. Furthermore, DNA sequence analysis allowed the determination of the putative replication and partitioning regions of pMT1. We identified a single 2,450-bp region within pMT1 that could function as the origin of replication, including a RepA-like protein similar to RepFIB, RepHI1B, and P1 and P7 replicons. Plasmid partitioning function was located ca. 36 kb from the putative origin of replication and was most similar to the parABS bacteriophage P1 and P7 system. Y. pestis pMT1 encoded potential genes with a high degree of similarity to a wide variety of organisms, plasmids, and bacteriophage. Accordingly, our analysis of the pMT1 DNA sequence emphasized the mosaic nature of this large bacterial virulence plasmid and provided implications as to its evolution.	66	12	5731-42		Lindler;Plano;Burland;Mayhew;Blattner	L E;G V;V;G F;F R	Department of Bacterial Diseases, Division of Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, USA. Dr._Luther_Lindler@wrsmtp-ccmail.army.mil	eng	Proc Natl Acad Sci U S A. 1981 Feb;78(2):1224-8;J Bacteriol. 1990 Oct;172(10):5929-37;J Med Microbiol. 1996 Dec;45(6):440-4;Gene. 1994 Feb 11;139(1):133-4;Infect Immun. 1990 Apr;58(4):1124-8;Microb Pathog. 1991 Feb;10(2):87-91;Proc Natl Acad Sci U S A. 1989 Jun;86(12):4412-5;FEBS Lett. 1997 Sep 22;415(1):40-4;Int J Parasitol. 1995 Dec;25(12):1385-91;Nucleic Acids Res. 1997 Apr 1;25(7):1355-61;Science. 1997 Sep 5;277(5331):1453-62;Microbiol Rev. 1994 Jun;58(2):162-210;Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S323-6;J Bacteriol. 1991 Oct;173(19):6058-65;Infect Immun. 1993 Jun;61(6):2486-92;Microb Pathog. 1993 Dec;15(6):485-95;Biochim Biophys Acta. 1975 Apr 2;383(4):457-63;Infect Immun. 1988 Oct;56(10):2743-8;J Gen Microbiol. 1993 Aug;139(8):1761-6;Science. 1992 Nov 6;258(5084):1004-7;Nucleic Acids Res. 1990 Sep 11;18(17):4993-5000;Mol Microbiol. 1992 May;6(9):1141-7;J Biol Chem. 1991 Aug 5;266(22):14399-405;Genetika. 1983 Jul;19(7):1081-90;Plasmid. 1987 Jul;18(1):93-8;EMBO J. 1988 Jun;7(6):1881-8;Rev Infect Dis. 1983 Sep-Oct;5 Suppl 4:S748-58;Prog Nucleic Acid Res Mol Biol. 1997;57:145-86;Annu Rev Biochem. 1995;64:141-69;Contrib Microbiol Immunol. 1995;13:321-4;Mol Microbiol. 1992 Feb;6(3):345-54;Nucleic Acids Res. 1998 Sep 15;26(18):4196-204;J Bacteriol. 1997 Mar;179(6):2081-5;Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8490-5;J Bacteriol. 1994 Dec;176(23):7280-90;FEMS Microbiol Lett. 1990 Jan 15;55(1-2):45-8;Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9228-32;J Med Entomol. 1993 Jul;30(4):772-80;Mol Microbiol. 1997 Mar;23(6):1089-97;Mol Microbiol. 1992 Mar;6(5):605-13;Nucleic Acids Res. 1988 Nov 25;16(22):10669-79;Infect Immun. 1991 Sep;59(9):3026-32;Prog Nucleic Acid Res Mol Biol. 1991;40:1-24;J Med Microbiol. 1995 Apr;42(4):264-8;J Mol Biol. 1982 Dec 25;162(4):729-73;Contrib Microbiol Immunol. 1995;13:299-305;Microbiology. 1995 Sep;141 ( Pt 9):2157-64;Proc Natl Acad Sci U S A. 1985 May;82(9):2588-92;Sov Genet. 1971 Apr;7(4):507-10;Genetics. 1996 Jul;143(3):1091-100;Microb Pathog. 1991 Aug;11(2):123-8;J Mol Biol. 1986 Nov 20;192(2):275-85;Virology. 1972 Feb;47(2):513-6;Plasmid. 1993 Jul;30(1):30-8;Nature. 1989 May 25;339(6222):254-5;Nucleic Acids Res. 1993 Jul 25;21(15):3385-90;Infect Immun. 1991 May;59(5):1860-3;Gene. 1998 Nov 26;223(1-2):47-54;Nucleic Acids Res. 1979 Nov 24;7(6):1513-23;J Mol Biol. 1994 Oct 21;243(2):190-8;EMBO J. 1996 Mar 1;15(5):1155-62;Proc Natl Acad Sci U S A. 1974 Apr;71(4):1342-6;Infect Immun. 1997 Nov;65(11):4606-14;Am J Physiol. 1991 Oct;261(4 Pt 2):F734-9;FEMS Microbiol Lett. 1995 Jun 15;129(2-3):287-92;FEBS Lett. 1992 Jun 22;305(1):37-40;J Biol Chem. 1994 Sep 9;269(36):22779-87;FEBS Lett. 1991 Jul 29;286(1-2):79-82;J Bacteriol. 1998 Oct;180(19):5192-202;EMBO J. 1993 Dec;12(12):4547-54;Clin Microbiol Rev. 1991 Jul;4(3):309-24;Infect Immun. 1981 Feb;31(2):839-41;Mol Biochem Parasitol. 1988 Dec;31(3):241-50;Genetica. 1992;86(1-3):99-111;Curr Top Microbiol Immunol. 1972;57:111-58;Nucleic Acids Res. 1995 Jun 25;23(12):2105-19;J Mol Biol. 1987 Aug 5;196(3):445-55;FEBS Lett. 1990 Dec 17;277(1-2):230-2;Curr Top Microbiol Immunol. 1985;118:29-51;Mol Microbiol. 1991 Mar;5(3):617-22;Infect Immun. 1996 Jan;64(1):375-9;Mol Microbiol. 1997 Feb;23(4):683-92;Plasmid. 1994 Mar;31(2):111-20;Annu Rev Biochem. 1995;64:287-314;Mol Microbiol. 1997 Sep;25(5):945-54;Proteins. 1991;11(2):95-110;Nucleic Acids Res. 1997 Sep 1;25(17):3389-402;Infect Immun. 1998 Aug;66(8):3810-7;Science. 1965 Jul 23;149(3682):422-4;Plasmid. 1994 Jul;32(1):75-9;J Biol Chem. 1995 Oct 20;270(42):24623-6;Genomics. 1995 Nov 20;30(2):273-80	MEDLINE	ppublish
